data_2rvk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rvk _Structure_validation_residue.Date_analyzed 2017-01-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.655 0.265 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.443 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.601 ' HG ' ' HZ2' ' A' ' 304' ' ' LYS . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.601 ' HZ2' ' HG ' ' A' ' 301' ' ' SER . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.482 ' NE ' HD22 ' A' ' 313' ' ' ASN . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.482 HD22 ' NE ' ' A' ' 311' ' ' ARG . 11.3 p30 -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 319' ' ' ALA . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.45 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.45 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 336' ' ' ILE . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 343' ' ' PRO . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.483 HD22 ' ND2' ' A' ' 391' ' ' ASN . 1.0 OUTLIER -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.528 ' NH2' ' HH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 388' ' ' ILE . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.483 ' ND2' HD22 ' A' ' 347' ' ' ASN . 87.4 m-20 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.528 ' HH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 275' ' ' ALA . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 15.5 m120 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.617 HH11 HD21 ' A' ' 313' ' ' ASN . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . 0.617 HD21 HH11 ' A' ' 311' ' ' ARG . 97.1 m-20 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.532 HE21 ' CD ' ' A' ' 330' ' ' GLN . 65.2 tp60 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.532 ' CD ' HE21 ' A' ' 326' ' ' GLN . 89.7 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 336' ' ' ILE . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.462 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.461 ' O ' ' CG ' ' A' ' 295' ' ' TYR . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.444 ' O ' ' OG ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.543 HE21 ' CD ' ' A' ' 330' ' ' GLN . 62.8 tp60 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.543 ' CD ' HE21 ' A' ' 326' ' ' GLN . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 342' ' ' ASN . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 365' ' ' ASP . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.46 ' H ' ' HG1' ' A' ' 384' ' ' THR . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 299' ' ' SER . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 292' ' ' LEU . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 342' ' ' ASN . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.455 ' O ' ' O ' ' A' ' 343' ' ' PRO . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 365' ' ' ASP . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 . . . . . 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 279' ' ' ALA . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.486 ' CZ ' ' O ' ' A' ' 280' ' ' THR . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 348' ' ' LEU . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 388' ' ' ILE . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.844 0.354 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 271' ' ' ASN . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 18.5 m120 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 332' ' ' LEU . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 330' ' ' GLN . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.545 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.548 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.548 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.475 ' CG ' ' H ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.475 ' H ' ' CG ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.621 ' H ' ' CD2' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.492 ' CD1' ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.492 ' H ' ' CD1' ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 314' ' ' VAL . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 319' ' ' ALA . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 343' ' ' PRO . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 348' ' ' LEU . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.408 HH11 ' C ' ' A' ' 358' ' ' ASP . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.408 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.541 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 375' ' ' PHE . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 373' ' ' PHE . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 317' ' ' SER . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.495 ' CD2' HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 336' ' ' ILE . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . 0.495 HE22 ' CD2' ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.549 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.795 0.331 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.42 ' CZ ' ' O ' ' A' ' 280' ' ' THR . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 319' ' ' ALA . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.416 HD11 ' H ' ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.538 HE21 ' CD ' ' A' ' 330' ' ' GLN . 69.0 tp60 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLN . . . . . 0.538 ' CD ' HE21 ' A' ' 326' ' ' GLN . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 343' ' ' PRO . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.07 -19.52 45.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.5 2.133 . . . . 0.0 111.189 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -157.54 -150.71 5.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -70.1 142.66 52.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.65 0.262 . . . . 0.0 110.295 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtt -64.57 -40.45 95.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.174 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.07 141.37 41.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 81.7 p -76.33 159.79 30.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.4 t 38.57 80.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.019 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.0 p -90.04 144.22 26.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -156.65 166.47 33.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.761 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.33 144.37 48.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.386 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -100.94 105.12 16.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -174.4 78.33 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.28 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.8 148.29 92.49 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.867 2.378 . . . . 0.0 111.821 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.4 m -61.57 -45.23 95.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 m -76.6 55.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.855 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.5 mt -76.39 149.33 36.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.312 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -65.47 -40.7 93.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.777 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -117.06 144.57 44.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -97.53 85.37 3.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 262' ' ' LEU . 9.4 mp 34.18 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.629 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -68.08 138.67 55.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.982 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -83.9 151.31 25.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.31 -66.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.623 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -161.9 79.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 55.68 36.47 27.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.7 t -71.77 145.39 48.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.5 p -158.71 158.64 34.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.16 -24.27 63.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -72.64 141.11 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.443 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.601 ' HG ' ' HZ2' ' A' ' 304' ' ' LYS . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.601 ' HZ2' ' HG ' ' A' ' 301' ' ' SER . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.482 ' NE ' HD22 ' A' ' 313' ' ' ASN . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.482 HD22 ' NE ' ' A' ' 311' ' ' ARG . 11.3 p30 -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 319' ' ' ALA . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.45 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.45 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 336' ' ' ILE . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.472 ' O ' ' O ' ' A' ' 343' ' ' PRO . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.483 HD22 ' ND2' ' A' ' 391' ' ' ASN . 1.0 OUTLIER -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.528 ' NH2' ' HH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 388' ' ' ILE . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.483 ' ND2' HD22 ' A' ' 347' ' ' ASN . 87.4 m-20 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.528 ' HH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 -115.43 92.34 32.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.76 136.02 64.22 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.12 1.88 . . . . 0.0 111.658 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -80.05 125.7 30.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.351 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.51 140.11 37.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.108 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 27.0 m -66.06 141.27 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.362 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 52.6 Cg_exo -53.31 -42.46 65.09 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.537 2.158 . . . . 0.0 111.69 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 77.09 13.18 83.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -88.5 -12.24 43.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.734 0.302 . . . . 0.0 110.725 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 18.3 tpp -84.49 134.26 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.842 0.353 . . . . 0.0 110.415 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.57 6.73 73.01 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.4 m -59.81 -36.55 77.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.102 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.72 142.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.046 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 19.8 m -89.13 153.08 21.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -82.33 94.63 7.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -86.92 -4.4 59.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.988 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.03 144.06 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.226 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.79 77.47 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.049 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.81 145.22 99.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.52 2.147 . . . . 0.0 111.717 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.8 m -103.35 129.91 50.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.208 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 73.5 p -68.7 149.84 48.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.388 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.5 43.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.413 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 258' ' ' LEU . 8.9 mp -62.25 -41.75 98.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.553 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -103.24 130.5 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.354 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -160.17 -22.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 261' ' ' LEU . 8.2 mp -89.49 134.77 33.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.65 -5.68 58.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.406 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.72 127.13 31.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.87 145.07 48.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.615 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.49 140.51 31.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.077 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.73 -40.78 92.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 56.88 43.74 24.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.589 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.2 p -72.69 163.04 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -134.87 139.7 45.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.956 0.407 . . . . 0.0 110.801 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -82.74 91.75 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -101.19 134.5 44.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.308 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 275' ' ' ALA . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 15.5 m120 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.617 HH11 HD21 ' A' ' 313' ' ' ASN . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . 0.617 HD21 HH11 ' A' ' 311' ' ' ARG . 97.1 m-20 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.532 HE21 ' CD ' ' A' ' 330' ' ' GLN . 65.2 tp60 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.532 ' CD ' HE21 ' A' ' 326' ' ' GLN . 89.7 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 336' ' ' ILE . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.47 80.34 45.6 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.53 144.29 99.46 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.418 2.079 . . . . 0.0 111.883 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -90.89 128.2 36.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -118.16 141.96 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.194 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 26.3 m -72.11 142.52 49.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.17 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.911 -1.043 . . . . 0.0 110.642 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.94 -38.68 86.43 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.723 2.282 . . . . 0.0 111.997 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 79.94 9.88 86.22 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 50.12 74.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtm -64.19 -40.57 96.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.007 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.5 130.85 2.27 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 37.2 p -156.47 162.31 39.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.38 -45.22 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.75 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.8 m -90.47 154.52 19.58 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 52.5 t30 54.02 37.89 27.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.853 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.22 144.99 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -63.01 -41.99 99.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.122 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.13 147.68 60.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.793 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.84 150.4 83.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.969 1.779 . . . . 0.0 112.009 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -98.57 53.82 1.03 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.543 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 72.4 m -101.49 -1.6 32.7 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.85 59.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.891 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.496 ' N ' ' CD1' ' A' ' 258' ' ' LEU . 8.3 mp -81.12 -6.03 58.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.376 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -62.98 -43.51 98.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.756 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -170.64 96.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.1 128.48 47.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.178 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 82.5 mt -104.89 130.47 53.03 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.474 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -139.57 143.93 37.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -85.27 102.28 13.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.236 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.4 169.35 4.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.871 0.367 . . . . 0.0 110.822 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 65.5 t30 54.96 68.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.865 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 84.1 p -59.96 -40.94 90.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.9 p -79.0 166.49 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -119.8 134.38 55.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.007 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -71.61 138.55 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.462 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.461 ' O ' ' CG ' ' A' ' 295' ' ' TYR . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.444 ' O ' ' OG ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.543 HE21 ' CD ' ' A' ' 330' ' ' GLN . 62.8 tp60 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.543 ' CD ' HE21 ' A' ' 326' ' ' GLN . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 342' ' ' ASN . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 365' ' ' ASP . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.46 ' H ' ' HG1' ' A' ' 384' ' ' THR . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -133.65 80.46 56.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.65 144.28 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.464 2.11 . . . . 0.0 112.046 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -95.99 121.39 37.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.983 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -97.51 108.7 21.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.44 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 36.7 t -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.596 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 52.8 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.711 179.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.92 155.55 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.805 2.337 . . . . 0.0 112.026 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.85 -21.5 1.14 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . 0.498 ' ND1' ' N ' ' A' ' 244' ' ' HIS . 0.0 OUTLIER -150.89 160.75 43.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.785 0.326 . . . . 0.0 110.508 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 99.4 mmm -65.18 -40.79 94.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.72 104.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.6 t -70.31 141.67 52.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.754 0.311 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 m -122.34 133.3 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.344 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.9 p -89.32 163.82 15.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -65.61 -38.88 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.02 -34.03 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.53 -10.74 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.319 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -134.32 77.06 61.21 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.31 146.56 97.19 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 65.7 p -129.24 158.28 39.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.0 t -67.67 143.95 55.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -157.81 -5.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.63 -42.21 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.274 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -139.08 137.76 36.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -164.17 51.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.095 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.96 -41.81 99.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.536 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.76 125.14 42.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 264' ' ' HIS . 84.3 tt0 -159.99 151.18 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.474 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 263' ' ' GLU . 85.9 m-70 57.93 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -84.17 -6.22 59.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.377 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -46.97 153.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.737 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.55 -40.23 96.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.03 89.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.302 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 21.0 m -72.55 146.77 46.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -156.0 -32.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.79 164.96 15.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 299' ' ' SER . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 292' ' ' LEU . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 342' ' ' ASN . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.455 ' O ' ' O ' ' A' ' 343' ' ' PRO . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 365' ' ' ASP . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 -119.13 87.96 35.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.83 146.52 97.36 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.164 1.909 . . . . 0.0 111.729 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -96.05 122.18 38.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.754 0.312 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.71 143.01 27.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.1 m -72.04 144.2 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.243 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.697 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.25 153.01 67.03 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.682 2.255 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 98.61 161.79 30.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -58.65 -45.78 88.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 110.365 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 98.5 mtp -84.77 142.26 29.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.381 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -58.56 -45.72 94.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.4 p -162.13 154.54 19.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.18 -46.31 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.876 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 12.6 m -99.15 150.38 22.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.101 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -83.63 151.34 25.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.415 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.16 143.02 54.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.17 118.26 31.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.32 75.4 0.67 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.261 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.77 143.14 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.451 2.1 . . . . 0.0 111.0 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.3 m -68.41 119.84 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.053 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 258' ' ' LEU . 6.6 m -95.42 -2.07 49.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.426 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.52 16.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 256' ' ' SER . 55.6 tp -60.66 -43.11 98.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.281 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -72.5 141.67 48.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.06 90.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.61 128.77 36.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.543 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.86 138.95 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 263' ' ' GLU . 57.6 mp0 -74.2 116.46 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.195 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -67.99 -40.24 83.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.809 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.88 141.55 31.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 267' ' ' ASN . 10.7 tm-20 -119.41 143.54 47.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.175 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.48 ' N ' ' CD ' ' A' ' 266' ' ' GLU . 23.0 m120 -84.57 98.82 10.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.569 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 85.6 p -81.99 167.44 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.426 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.6 p -152.22 155.66 38.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.953 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -143.3 104.05 4.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -159.77 173.52 15.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.409 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 279' ' ' ALA . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.486 ' CZ ' ' O ' ' A' ' 280' ' ' THR . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 348' ' ' LEU . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 388' ' ' ILE . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 -116.93 85.43 17.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.81 144.99 92.48 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.205 1.937 . . . . 0.0 111.397 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.78 118.12 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.663 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.85 141.92 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.496 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 73.6 m -63.43 143.47 57.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.465 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.574 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 51.3 Cg_exo -54.0 -41.07 78.3 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.635 2.223 . . . . 0.0 112.331 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -169.04 -178.7 40.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 245' ' ' MET . 54.4 t-80 -80.88 139.22 36.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.627 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' MET . . . . . 0.511 ' O ' ' CE1' ' A' ' 244' ' ' HIS . 83.8 mtp -81.36 133.67 35.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.132 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.1 158.19 27.74 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.3 t -72.8 140.76 47.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.669 0.271 . . . . 0.0 110.391 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.15 -46.5 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 85.6 p -89.79 162.96 15.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -156.92 170.6 22.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.048 0.451 . . . . 0.0 111.266 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.95 170.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.112 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.65 -43.99 97.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 49.48 60.47 15.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.11 150.39 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.726 2.284 . . . . 0.0 112.202 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 256' ' ' SER . 34.0 p -67.53 -32.23 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 255' ' ' THR . 2.9 p 81.81 23.88 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.212 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.1 -10.26 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.14 -41.53 98.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -67.49 127.24 31.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -74.46 136.41 42.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.761 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.14 -60.6 1.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.101 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.39 -42.88 98.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.54 151.36 32.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.454 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -98.78 127.09 44.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.744 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -80.24 116.44 20.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 266' ' ' GLU . 2.6 pm0 -83.73 160.82 21.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -63.18 -40.16 96.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.6 t -149.47 153.34 37.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.815 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.1 p -151.37 162.12 41.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.31 -40.94 90.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.497 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 -74.96 140.74 43.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.721 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 271' ' ' ASN . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 18.5 m120 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 332' ' ' LEU . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 330' ' ' GLN . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.438 HD22 ' HG ' ' A' ' 399' ' ' SER . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.545 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.91 81.77 45.16 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.87 142.24 92.94 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.418 2.079 . . . . 0.0 111.733 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . 0.426 ' CE2' ' O ' ' A' ' 398' ' ' LYS . 86.5 t80 -132.27 143.2 49.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.473 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.426 ' O ' ' CE2' ' A' ' 397' ' ' PHE . 50.6 mtmt -70.3 139.52 52.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' SER . . . . . 0.438 ' HG ' HD22 ' A' ' 342' ' ' ASN . 40.9 t -129.3 142.02 50.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.852 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.76 145.96 52.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.774 2.316 . . . . 0.0 111.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 161.3 153.94 7.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -67.64 -40.8 84.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.188 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.13 144.01 29.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.622 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.28 -23.84 0.28 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.6 m 45.41 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.288 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.11 134.18 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 18.5 m -89.72 142.68 27.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.277 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 92.2 m-20 -148.13 -81.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.92 -24.8 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.27 -11.16 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.66 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.85 75.57 35.97 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.395 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.59 147.12 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.814 2.343 . . . . 0.0 112.27 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 43.7 p -85.45 134.15 34.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 258' ' ' LEU . 38.4 t -156.44 169.11 25.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.156 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.78 35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.568 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.517 ' H ' ' C ' ' A' ' 256' ' ' SER . 9.1 mp 58.62 37.84 25.25 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.953 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -84.07 143.06 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.812 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -105.41 53.76 0.71 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.15 -41.74 99.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 83.7 mt -100.71 -164.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 264' ' ' HIS . 97.6 mt-10 52.24 89.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 263' ' ' GLU . 96.1 m-70 47.72 179.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.63 133.16 37.94 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -94.52 128.06 40.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -87.79 103.43 15.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.344 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.9 m -78.12 -7.06 56.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 70.5 m -72.48 146.56 46.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.691 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -173.11 88.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -74.09 142.1 45.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.548 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.548 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.475 ' CG ' ' H ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.475 ' H ' ' CG ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.621 ' CD2' ' H ' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.492 ' CD1' ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.492 ' H ' ' CD1' ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 -97.9 107.14 38.69 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.08 145.36 92.46 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.466 1.444 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -86.84 121.94 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.897 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -81.29 133.29 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 13.5 m -73.13 148.86 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.226 179.723 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.18 151.7 76.74 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.814 2.343 . . . . 0.0 111.956 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -63.17 -37.13 94.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.21 127.09 31.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 0.0 110.502 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 65.4 mtt -129.79 156.27 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.029 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.3 33.53 39.47 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.8 m -59.54 -36.12 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.592 0.234 . . . . 0.0 110.521 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.6 t -83.76 120.86 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 58.5 m -130.35 154.52 47.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.64 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.15 -40.19 96.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -137.96 151.95 48.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.57 -42.8 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.015 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 43.88 58.29 12.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.17 143.97 73.33 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.611 2.207 . . . . 0.0 111.872 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 256' ' ' SER . 27.1 m -161.72 -61.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.409 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 255' ' ' THR . 3.5 m 56.14 130.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.282 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.44 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.35 141.47 47.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.288 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -67.27 -40.96 86.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -127.28 150.71 49.44 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 81.1 mt -63.17 -40.04 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.717 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 10.7 mp -76.02 138.23 40.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.055 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -150.81 -20.85 0.22 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -79.08 148.24 32.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.637 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.88 150.65 44.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.37 -3.85 23.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.11 107.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 56.6 m -63.47 -42.48 98.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 69.4 m -129.66 152.83 48.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -101.77 128.93 47.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -94.81 132.78 39.22 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 314' ' ' VAL . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 319' ' ' ALA . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 343' ' ' PRO . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 348' ' ' LEU . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.408 HH11 ' C ' ' A' ' 358' ' ' ASP . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.408 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.541 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 375' ' ' PHE . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 373' ' ' PHE . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 -134.05 77.64 61.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.43 144.37 99.51 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.476 2.117 . . . . 0.0 111.709 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -88.63 124.58 34.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.01 142.35 41.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 47.5 t -71.11 140.17 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.321 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.607 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.32 -37.17 88.62 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.582 2.188 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -174.82 175.74 46.99 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -65.36 -40.89 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.667 0.27 . . . . 0.0 110.51 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 40.3 tpp -90.17 131.77 35.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -83.02 97.17 1.96 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 t -68.69 -17.4 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 110.798 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.85 -44.42 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 21.5 t -122.82 148.07 45.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.822 0.344 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.64 141.05 30.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.976 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.14 74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.393 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -81.05 141.9 33.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.028 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -155.9 57.31 1.49 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.003 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.81 -23.29 62.74 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.341 2.027 . . . . 0.0 111.352 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.5 p -137.18 161.53 35.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.8 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 30.3 p -74.88 155.26 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.273 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.9 -27.76 10.02 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.744 0.306 . . . . 0.0 110.571 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.91 -42.41 99.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.478 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -76.41 139.88 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -168.23 -10.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 262' ' ' LEU . 87.3 mt -84.36 117.52 23.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 261' ' ' LEU . 79.8 mt 51.66 113.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -64.79 -36.11 83.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.531 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -79.63 131.36 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.791 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.75 -41.58 99.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.61 157.23 32.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.726 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -88.01 106.56 18.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 55.3 m -127.32 27.4 5.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.3 p -72.45 158.62 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.078 0.466 . . . . 0.0 111.059 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 -16.77 42.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.64 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -71.8 120.81 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 317' ' ' SER . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.495 ' CD2' HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 336' ' ' ILE . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . 0.495 HE22 ' CD2' ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.549 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.73 84.04 39.97 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.14 144.31 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.252 1.968 . . . . 0.0 111.373 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -79.21 129.44 34.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -89.69 136.61 32.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.5 m -73.08 150.51 42.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.382 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.327 179.533 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.52 144.92 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.779 2.319 . . . . 0.0 111.752 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.92 175.8 53.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -63.32 116.73 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 7.2 ttt -141.54 130.65 23.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.926 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -168.56 171.98 42.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.646 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.4 p -158.08 166.04 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.7 154.21 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.3 p -89.51 168.18 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.067 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 253' ' ' ALA . 59.6 t30 -77.82 115.94 17.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.693 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -142.2 -55.72 0.44 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.26 -43.33 95.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 250' ' ' ASN . . . -173.5 154.54 2.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.211 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' A' ' 255' ' ' THR . 51.1 Cg_exo -51.29 -45.28 38.11 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.426 1.417 . . . . 0.0 111.925 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 254' ' ' PRO . 94.0 m -168.37 106.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 258' ' ' LEU . 72.2 m -73.44 -64.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.631 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 56.14 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 256' ' ' SER . 56.4 tp -160.69 110.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.043 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 260' ' ' ALA . 36.4 mmt180 -106.15 -9.68 16.82 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 259' ' ' ARG . . . 57.61 117.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.87 -39.77 95.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.615 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.37 135.9 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -88.7 -74.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.47 141.28 45.32 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.669 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -85.44 -12.91 50.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.435 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.64 -40.67 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.525 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -86.48 112.46 21.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.251 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.9 m -105.08 49.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.6 p -60.88 -35.37 76.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.46 143.99 54.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.736 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -85.08 152.85 23.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.624 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.42 ' CZ ' ' O ' ' A' ' 280' ' ' THR . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 319' ' ' ALA . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.416 HD11 ' H ' ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.538 HE21 ' CD ' ' A' ' 330' ' ' GLN . 69.0 tp60 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLN . . . . . 0.538 ' CD ' HE21 ' A' ' 326' ' ' GLN . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 333' ' ' VAL . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 343' ' ' PRO . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.544 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -134.64 82.8 43.98 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.34 144.18 96.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 111.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -79.22 128.61 33.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.701 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.92 144.57 25.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.6 m -72.74 146.14 46.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.828 -179.793 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.655 0.265 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.586 ' HB3' HG11 ' A' ' 314' ' ' VAL . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 294' ' ' ILE . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 296' ' ' PHE . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 281' ' ' PHE . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 368' ' ' GLY . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 320' ' ' ILE . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.481 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.481 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 388' ' ' ILE . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.44 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 375' ' ' PHE . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.447 HD12 ' CE2' ' A' ' 378' ' ' PHE . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.498 ' NH2' ' OH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 350' ' ' ILE . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 346' ' ' TRP . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ASN . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.498 ' OH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 280' ' ' THR . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 276' ' ' GLU . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 91.0 m-20 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.456 HG21 ' CE2' ' A' ' 296' ' ' PHE . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 294' ' ' ILE . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 314' ' ' VAL . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 366' ' ' ARG . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 368' ' ' GLY . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.429 ' HG3' HE21 ' A' ' 330' ' ' GLN . 10.0 tp-100 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.429 HE21 ' HG3' ' A' ' 326' ' ' GLN . 32.3 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 381' ' ' VAL . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.457 HD11 ' CE1' ' A' ' 378' ' ' PHE . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.572 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 296' ' ' PHE . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 294' ' ' ILE . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 368' ' ' GLY . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 323' ' ' ILE . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 HE22 ' A' ' 341' ' ' GLN . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 332' ' ' LEU . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.556 HE22 HD21 ' A' ' 324' ' ' LEU . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 388' ' ' ILE . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.571 ' NH1' HD22 ' A' ' 357' ' ' LEU . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.571 HD22 ' NH1' ' A' ' 349' ' ' ARG . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 364' ' ' LEU . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 367' ' ' VAL . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 344' ' ' ASN . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 280' ' ' THR . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 276' ' ' GLU . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.436 HD12 ' OE1' ' A' ' 326' ' ' GLN . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.567 ' C ' HD22 ' A' ' 310' ' ' LEU . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 309' ' ' GLU . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 314' ' ' VAL . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 368' ' ' GLY . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.436 ' OE1' HD12 ' A' ' 306' ' ' LEU . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 388' ' ' ILE . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.458 ' HB3' HD11 ' A' ' 380' ' ' LEU . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.482 ' HB2' HG11 ' A' ' 381' ' ' VAL . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 362' ' ' PRO . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 354' ' ' ASP . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 352' ' ' GLU . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.688 ' HG3' HD12 ' A' ' 350' ' ' ILE . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 364' ' ' LEU . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 346' ' ' TRP . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 344' ' ' ASN . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 . . . . . 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 294' ' ' ILE . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.456 HD11 HD21 ' A' ' 292' ' ' LEU . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 311' ' ' ARG . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.631 ' N ' HD22 ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 368' ' ' GLY . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 323' ' ' ILE . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 320' ' ' ILE . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 325' ' ' LEU . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 329' ' ' ASN . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 328' ' ' VAL . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 348' ' ' LEU . 3.4 m-20 -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 347' ' ' ASN . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.591 ' O ' HD12 ' A' ' 315' ' ' LEU . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 367' ' ' VAL . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 378' ' ' PHE . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 370' ' ' LEU . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 347' ' ' ASN . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.844 0.354 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.786 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.786 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 276' ' ' GLU . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.738 ' HB3' HG11 ' A' ' 314' ' ' VAL . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 80.0 m-20 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 295' ' ' TYR . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 294' ' ' ILE . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.509 ' HB2' HG22 ' A' ' 314' ' ' VAL . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 281' ' ' PHE . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 366' ' ' ARG . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 323' ' ' ILE . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 340' ' ' ALA . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 383' ' ' ALA . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 378' ' ' PHE . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 364' ' ' LEU . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 381' ' ' VAL . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 345' ' ' TYR . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.605 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.605 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 280' ' ' THR . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 276' ' ' GLU . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 311' ' ' ARG . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 357' ' ' LEU . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.516 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 367' ' ' VAL . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.763 ' H ' HD12 ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 364' ' ' LEU . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.421 ' H ' ' HB2' ' A' ' 387' ' ' GLN . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 384' ' ' THR . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 294' ' ' ILE . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 292' ' ' LEU . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 368' ' ' GLY . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 323' ' ' ILE . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 320' ' ' ILE . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.573 ' HB3' HD11 ' A' ' 380' ' ' LEU . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 348' ' ' LEU . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.463 HD22 ' C ' ' A' ' 347' ' ' ASN . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.519 ' HB2' HG11 ' A' ' 381' ' ' VAL . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ILE . . . . . 0.685 HD12 ' HG2' ' A' ' 362' ' ' PRO . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.632 ' N ' HD22 ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.428 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 350' ' ' ILE . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 364' ' ' LEU . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.518 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 346' ' ' TRP . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 391' ' ' ASN . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 280' ' ' THR . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 276' ' ' GLU . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 294' ' ' ILE . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.467 HD11 HD21 ' A' ' 292' ' ' LEU . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 368' ' ' GLY . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.746 HD21 HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 332' ' ' LEU . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 339' ' ' GLU . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.466 ' HB1' ' NE1' ' A' ' 346' ' ' TRP . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.746 HE22 HD21 ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.426 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 378' ' ' PHE . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.535 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 364' ' ' LEU . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 384' ' ' THR . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.795 0.331 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.528 ' HB3' HG11 ' A' ' 314' ' ' VAL . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.431 HD23 ' HG2' ' A' ' 312' ' ' LYS . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 370' ' ' LEU . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 322' ' ' TYR . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.532 ' HB2' HG13 ' A' ' 314' ' ' VAL . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' HD23 ' A' ' 290' ' ' LEU . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 311' ' ' ARG . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 368' ' ' GLY . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 323' ' ' ILE . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD2' HG11 ' A' ' 308' ' ' VAL . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 332' ' ' LEU . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.448 ' O ' ' NE2' ' A' ' 341' ' ' GLN . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 338' ' ' ASP . 0.7 OUTLIER -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.544 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 367' ' ' VAL . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.657 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.657 ' CZ ' HD11 ' A' ' 370' ' ' LEU . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 346' ' ' TRP . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 388' ' ' ILE . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 385' ' ' PRO . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.07 -19.52 45.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.5 2.133 . . . . 0.0 111.189 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -157.54 -150.71 5.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -70.1 142.66 52.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.65 0.262 . . . . 0.0 110.295 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtt -64.57 -40.45 95.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.174 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.07 141.37 41.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 81.7 p -76.33 159.79 30.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.4 t 38.57 80.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.019 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.0 p -90.04 144.22 26.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -156.65 166.47 33.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.761 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.33 144.37 48.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.386 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -100.94 105.12 16.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -174.4 78.33 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.28 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.8 148.29 92.49 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.867 2.378 . . . . 0.0 111.821 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.4 m -61.57 -45.23 95.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 m -76.6 55.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.855 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.5 mt -76.39 149.33 36.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.312 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -65.47 -40.7 93.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.777 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -117.06 144.57 44.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -97.53 85.37 3.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 262' ' ' LEU . 9.4 mp 34.18 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.629 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -68.08 138.67 55.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.982 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -83.9 151.31 25.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.31 -66.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.623 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -161.9 79.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 55.68 36.47 27.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.7 t -71.77 145.39 48.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.5 p -158.71 158.64 34.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.16 -24.27 63.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -72.64 141.11 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.586 ' HB3' HG11 ' A' ' 314' ' ' VAL . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 294' ' ' ILE . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 296' ' ' PHE . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 281' ' ' PHE . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 368' ' ' GLY . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 320' ' ' ILE . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.481 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.481 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 388' ' ' ILE . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.44 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 375' ' ' PHE . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.447 HD12 ' CE2' ' A' ' 378' ' ' PHE . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.498 ' NH2' ' OH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 350' ' ' ILE . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 346' ' ' TRP . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ASN . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.498 ' OH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 -115.43 92.34 32.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.76 136.02 64.22 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.12 1.88 . . . . 0.0 111.658 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -80.05 125.7 30.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.351 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.51 140.11 37.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.108 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 27.0 m -66.06 141.27 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.362 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 52.6 Cg_exo -53.31 -42.46 65.09 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.537 2.158 . . . . 0.0 111.69 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 77.09 13.18 83.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -88.5 -12.24 43.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.734 0.302 . . . . 0.0 110.725 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 18.3 tpp -84.49 134.26 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.842 0.353 . . . . 0.0 110.415 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.57 6.73 73.01 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.4 m -59.81 -36.55 77.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.102 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.72 142.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.046 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 19.8 m -89.13 153.08 21.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -82.33 94.63 7.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -86.92 -4.4 59.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.988 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.03 144.06 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.226 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.79 77.47 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.049 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.81 145.22 99.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.52 2.147 . . . . 0.0 111.717 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.8 m -103.35 129.91 50.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.208 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 73.5 p -68.7 149.84 48.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.388 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.5 43.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.413 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 258' ' ' LEU . 8.9 mp -62.25 -41.75 98.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.553 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -103.24 130.5 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.354 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -160.17 -22.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 261' ' ' LEU . 8.2 mp -89.49 134.77 33.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.65 -5.68 58.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.406 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.72 127.13 31.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -120.87 145.07 48.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.615 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.49 140.51 31.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.077 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.73 -40.78 92.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 56.88 43.74 24.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.589 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.2 p -72.69 163.04 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -134.87 139.7 45.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.956 0.407 . . . . 0.0 110.801 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -82.74 91.75 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -101.19 134.5 44.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.308 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 280' ' ' THR . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 276' ' ' GLU . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 91.0 m-20 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.456 HG21 ' CE2' ' A' ' 296' ' ' PHE . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 294' ' ' ILE . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 314' ' ' VAL . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 366' ' ' ARG . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 368' ' ' GLY . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.429 ' HG3' HE21 ' A' ' 330' ' ' GLN . 10.0 tp-100 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.429 HE21 ' HG3' ' A' ' 326' ' ' GLN . 32.3 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 381' ' ' VAL . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.457 HD11 ' CE1' ' A' ' 378' ' ' PHE . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.47 80.34 45.6 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.53 144.29 99.46 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.418 2.079 . . . . 0.0 111.883 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -90.89 128.2 36.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -118.16 141.96 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.194 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 26.3 m -72.11 142.52 49.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.17 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.911 -1.043 . . . . 0.0 110.642 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.94 -38.68 86.43 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.723 2.282 . . . . 0.0 111.997 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 79.94 9.88 86.22 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 50.12 74.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtm -64.19 -40.57 96.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.007 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.5 130.85 2.27 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 37.2 p -156.47 162.31 39.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 249' ' ' SER . 35.0 m -63.38 -45.22 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.75 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.514 ' N ' HG23 ' A' ' 248' ' ' VAL . 23.8 m -90.47 154.52 19.58 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 52.5 t30 54.02 37.89 27.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.853 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.22 144.99 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -63.01 -41.99 99.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.122 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.13 147.68 60.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.793 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.84 150.4 83.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.969 1.779 . . . . 0.0 112.009 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -98.57 53.82 1.03 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.543 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 72.4 m -101.49 -1.6 32.7 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.85 59.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.891 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 258' ' ' LEU . 8.3 mp -81.12 -6.03 58.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.376 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -62.98 -43.51 98.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.756 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -170.64 96.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.1 128.48 47.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.178 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 82.5 mt -104.89 130.47 53.03 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.474 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -139.57 143.93 37.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -85.27 102.28 13.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.236 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.4 169.35 4.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.871 0.367 . . . . 0.0 110.822 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 65.5 t30 54.96 68.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.865 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 84.1 p -59.96 -40.94 90.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.9 p -79.0 166.49 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -119.8 134.38 55.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.007 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -71.61 138.55 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.572 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 296' ' ' PHE . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 294' ' ' ILE . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 368' ' ' GLY . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 323' ' ' ILE . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 HE22 ' A' ' 341' ' ' GLN . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 332' ' ' LEU . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.556 HE22 HD21 ' A' ' 324' ' ' LEU . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 388' ' ' ILE . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.571 ' NH1' HD22 ' A' ' 357' ' ' LEU . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.571 HD22 ' NH1' ' A' ' 349' ' ' ARG . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 364' ' ' LEU . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 367' ' ' VAL . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 344' ' ' ASN . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -133.65 80.46 56.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.65 144.28 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.464 2.11 . . . . 0.0 112.046 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -95.99 121.39 37.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.983 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -97.51 108.7 21.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.44 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 36.7 t -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.596 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 52.8 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.711 179.847 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.92 155.55 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.805 2.337 . . . . 0.0 112.026 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.85 -21.5 1.14 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' HIS . . . . . 0.498 ' N ' ' ND1' ' A' ' 244' ' ' HIS . 0.0 OUTLIER -150.89 160.75 43.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.785 0.326 . . . . 0.0 110.508 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 99.4 mmm -65.18 -40.79 94.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.72 104.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.6 t -70.31 141.67 52.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.754 0.311 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 m -122.34 133.3 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.344 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.9 p -89.32 163.82 15.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -65.61 -38.88 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.02 -34.03 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.53 -10.74 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.319 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -134.32 77.06 61.21 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.31 146.56 97.19 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 65.7 p -129.24 158.28 39.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.0 t -67.67 143.95 55.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 258' ' ' LEU . . . -157.81 -5.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 257' ' ' ALA . 82.3 mt -62.63 -42.21 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.274 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -139.08 137.76 36.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -164.17 51.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.095 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.96 -41.81 99.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.536 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.76 125.14 42.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 264' ' ' HIS . 84.3 tt0 -159.99 151.18 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.474 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 263' ' ' GLU . 85.9 m-70 57.93 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -84.17 -6.22 59.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.377 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -46.97 153.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.737 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.55 -40.23 96.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.03 89.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.302 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 21.0 m -72.55 146.77 46.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -156.0 -32.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.79 164.96 15.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 280' ' ' THR . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 276' ' ' GLU . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.436 HD12 ' OE1' ' A' ' 326' ' ' GLN . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.567 ' C ' HD22 ' A' ' 310' ' ' LEU . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 309' ' ' GLU . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 314' ' ' VAL . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 368' ' ' GLY . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.436 ' OE1' HD12 ' A' ' 306' ' ' LEU . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 388' ' ' ILE . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.458 ' HB3' HD11 ' A' ' 380' ' ' LEU . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.482 ' HB2' HG11 ' A' ' 381' ' ' VAL . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 362' ' ' PRO . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 354' ' ' ASP . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 352' ' ' GLU . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.688 ' HG3' HD12 ' A' ' 350' ' ' ILE . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 364' ' ' LEU . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 346' ' ' TRP . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 344' ' ' ASN . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 -119.13 87.96 35.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.83 146.52 97.36 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.164 1.909 . . . . 0.0 111.729 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -96.05 122.18 38.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.754 0.312 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.71 143.01 27.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.1 m -72.04 144.2 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.243 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.697 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.25 153.01 67.03 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.682 2.255 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 98.61 161.79 30.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -58.65 -45.78 88.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 110.365 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 98.5 mtp -84.77 142.26 29.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.381 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -58.56 -45.72 94.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.4 p -162.13 154.54 19.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.18 -46.31 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.876 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 12.6 m -99.15 150.38 22.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.101 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -83.63 151.34 25.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.415 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.16 143.02 54.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.17 118.26 31.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.32 75.4 0.67 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.261 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.77 143.14 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.451 2.1 . . . . 0.0 111.0 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.3 m -68.41 119.84 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.053 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 258' ' ' LEU . 6.6 m -95.42 -2.07 49.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.426 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.52 16.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 256' ' ' SER . 55.6 tp -60.66 -43.11 98.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.281 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -72.5 141.67 48.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.06 90.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.61 128.77 36.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.543 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.86 138.95 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 263' ' ' GLU . 57.6 mp0 -74.2 116.46 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.195 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -67.99 -40.24 83.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.809 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.88 141.55 31.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 267' ' ' ASN . 10.7 tm-20 -119.41 143.54 47.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.175 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.48 ' N ' ' CD ' ' A' ' 266' ' ' GLU . 23.0 m120 -84.57 98.82 10.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.569 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 85.6 p -81.99 167.44 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.426 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.6 p -152.22 155.66 38.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.953 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -143.3 104.05 4.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -159.77 173.52 15.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 294' ' ' ILE . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.456 HD11 HD21 ' A' ' 292' ' ' LEU . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 311' ' ' ARG . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.631 ' N ' HD22 ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 368' ' ' GLY . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 323' ' ' ILE . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.409 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 320' ' ' ILE . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 325' ' ' LEU . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 329' ' ' ASN . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 328' ' ' VAL . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 348' ' ' LEU . 3.4 m-20 -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 347' ' ' ASN . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.591 ' O ' HD12 ' A' ' 315' ' ' LEU . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 367' ' ' VAL . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 378' ' ' PHE . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 370' ' ' LEU . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 347' ' ' ASN . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 -116.93 85.43 17.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.81 144.99 92.48 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.205 1.937 . . . . 0.0 111.397 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.78 118.12 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.663 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.85 141.92 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.496 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 73.6 m -63.43 143.47 57.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.465 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.574 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 51.3 Cg_exo -54.0 -41.07 78.3 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.635 2.223 . . . . 0.0 112.331 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -169.04 -178.7 40.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 245' ' ' MET . 54.4 t-80 -80.88 139.22 36.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.627 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' MET . . . . . 0.511 ' O ' ' CE1' ' A' ' 244' ' ' HIS . 83.8 mtp -81.36 133.67 35.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.132 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.1 158.19 27.74 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.3 t -72.8 140.76 47.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.669 0.271 . . . . 0.0 110.391 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.15 -46.5 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 85.6 p -89.79 162.96 15.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -156.92 170.6 22.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.048 0.451 . . . . 0.0 111.266 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.95 170.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.112 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.65 -43.99 97.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 49.48 60.47 15.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.11 150.39 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.726 2.284 . . . . 0.0 112.202 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 256' ' ' SER . 34.0 p -67.53 -32.23 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 255' ' ' THR . 2.9 p 81.81 23.88 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.212 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.1 -10.26 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 258' ' ' LEU . 10.6 mp -62.14 -41.53 98.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -67.49 127.24 31.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -74.46 136.41 42.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.761 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.14 -60.6 1.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.101 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.39 -42.88 98.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.54 151.36 32.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.454 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -98.78 127.09 44.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.744 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -80.24 116.44 20.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.645 ' H ' ' CD ' ' A' ' 266' ' ' GLU . 2.6 pm0 -83.73 160.82 21.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -63.18 -40.16 96.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.6 t -149.47 153.34 37.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.815 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.1 p -151.37 162.12 41.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.31 -40.94 90.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.497 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 -74.96 140.74 43.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.721 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.786 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.786 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 276' ' ' GLU . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.738 ' HB3' HG11 ' A' ' 314' ' ' VAL . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 80.0 m-20 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 295' ' ' TYR . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 294' ' ' ILE . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.509 ' HB2' HG22 ' A' ' 314' ' ' VAL . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 281' ' ' PHE . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 366' ' ' ARG . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 323' ' ' ILE . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 340' ' ' ALA . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 383' ' ' ALA . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 378' ' ' PHE . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 364' ' ' LEU . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 381' ' ' VAL . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 345' ' ' TYR . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.91 81.77 45.16 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.87 142.24 92.94 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.418 2.079 . . . . 0.0 111.733 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PHE . . . . . 0.426 ' CE2' ' O ' ' A' ' 398' ' ' LYS . 86.5 t80 -132.27 143.2 49.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.473 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.426 ' O ' ' CE2' ' A' ' 397' ' ' PHE . 50.6 mtmt -70.3 139.52 52.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.9 t -129.3 142.02 50.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.694 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.852 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.76 145.96 52.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.774 2.316 . . . . 0.0 111.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 161.3 153.94 7.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -67.64 -40.8 84.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.188 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.13 144.01 29.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.622 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.28 -23.84 0.28 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.6 m 45.41 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.288 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.11 134.18 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 18.5 m -89.72 142.68 27.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.277 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 92.2 m-20 -148.13 -81.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.92 -24.8 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.27 -11.16 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.66 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.85 75.57 35.97 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.395 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.59 147.12 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.814 2.343 . . . . 0.0 112.27 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 43.7 p -85.45 134.15 34.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 258' ' ' LEU . 38.4 t -156.44 169.11 25.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.156 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.78 35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.568 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 258' ' ' LEU . 9.1 mp 58.62 37.84 25.25 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.953 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -84.07 143.06 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.812 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -105.41 53.76 0.71 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.15 -41.74 99.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 83.7 mt -100.71 -164.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 264' ' ' HIS . 97.6 mt-10 52.24 89.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 263' ' ' GLU . 96.1 m-70 47.72 179.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.63 133.16 37.94 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -94.52 128.06 40.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -87.79 103.43 15.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.344 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.9 m -78.12 -7.06 56.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 70.5 m -72.48 146.56 46.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.691 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -173.11 88.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -74.09 142.1 45.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.605 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.605 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 280' ' ' THR . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 276' ' ' GLU . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 311' ' ' ARG . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 357' ' ' LEU . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.516 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 367' ' ' VAL . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.763 ' H ' HD12 ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 364' ' ' LEU . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.421 ' H ' ' HB2' ' A' ' 387' ' ' GLN . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 384' ' ' THR . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 -97.9 107.14 38.69 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.08 145.36 92.46 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.466 1.444 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -86.84 121.94 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.897 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -81.29 133.29 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 13.5 m -73.13 148.86 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.226 179.723 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.18 151.7 76.74 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.814 2.343 . . . . 0.0 111.956 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -63.17 -37.13 94.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.21 127.09 31.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 0.0 110.502 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 65.4 mtt -129.79 156.27 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.029 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.3 33.53 39.47 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.8 m -59.54 -36.12 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.592 0.234 . . . . 0.0 110.521 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.6 t -83.76 120.86 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 58.5 m -130.35 154.52 47.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.64 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.15 -40.19 96.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -137.96 151.95 48.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.57 -42.8 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.015 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 43.88 58.29 12.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.17 143.97 73.33 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.611 2.207 . . . . 0.0 111.872 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 256' ' ' SER . 27.1 m -161.72 -61.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.409 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 255' ' ' THR . 3.5 m 56.14 130.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.282 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.44 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.35 141.47 47.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.288 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -67.27 -40.96 86.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -127.28 150.71 49.44 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 81.1 mt -63.17 -40.04 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.717 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 262' ' ' LEU . 10.7 mp -76.02 138.23 40.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.055 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 264' ' ' HIS . 81.9 tt0 -150.81 -20.85 0.22 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' HIS . . . . . 0.405 ' H ' ' H ' ' A' ' 263' ' ' GLU . 96.1 m-70 -79.08 148.24 32.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.637 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.88 150.65 44.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.37 -3.85 23.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.11 107.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 56.6 m -63.47 -42.48 98.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 69.4 m -129.66 152.83 48.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -101.77 128.93 47.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -94.81 132.78 39.22 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 294' ' ' ILE . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 292' ' ' LEU . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 368' ' ' GLY . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 323' ' ' ILE . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 320' ' ' ILE . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.573 ' HB3' HD11 ' A' ' 380' ' ' LEU . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 348' ' ' LEU . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.463 HD22 ' C ' ' A' ' 347' ' ' ASN . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.519 ' HB2' HG11 ' A' ' 381' ' ' VAL . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ILE . . . . . 0.685 HD12 ' HG2' ' A' ' 362' ' ' PRO . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.632 ' N ' HD22 ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.428 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 350' ' ' ILE . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 364' ' ' LEU . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.518 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 346' ' ' TRP . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 391' ' ' ASN . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 -134.05 77.64 61.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.43 144.37 99.51 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.476 2.117 . . . . 0.0 111.709 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -88.63 124.58 34.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.01 142.35 41.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 47.5 t -71.11 140.17 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.321 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.607 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.32 -37.17 88.62 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.582 2.188 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -174.82 175.74 46.99 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -65.36 -40.89 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.667 0.27 . . . . 0.0 110.51 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 40.3 tpp -90.17 131.77 35.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -83.02 97.17 1.96 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 t -68.69 -17.4 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 110.798 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.85 -44.42 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 21.5 t -122.82 148.07 45.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.822 0.344 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -96.64 141.05 30.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.976 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.14 74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.393 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -81.05 141.9 33.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.028 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -155.9 57.31 1.49 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.003 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.81 -23.29 62.74 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.341 2.027 . . . . 0.0 111.352 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.5 p -137.18 161.53 35.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.8 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 30.3 p -74.88 155.26 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.273 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.9 -27.76 10.02 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.744 0.306 . . . . 0.0 110.571 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.91 -42.41 99.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.478 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -76.41 139.88 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -168.23 -10.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 262' ' ' LEU . 87.3 mt -84.36 117.52 23.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 261' ' ' LEU . 79.8 mt 51.66 113.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -64.79 -36.11 83.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.531 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -79.63 131.36 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.791 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.75 -41.58 99.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.61 157.23 32.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.726 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -88.01 106.56 18.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 55.3 m -127.32 27.4 5.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.3 p -72.45 158.62 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.078 0.466 . . . . 0.0 111.059 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 -16.77 42.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.64 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -71.8 120.81 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 280' ' ' THR . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 276' ' ' GLU . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 294' ' ' ILE . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.467 HD11 HD21 ' A' ' 292' ' ' LEU . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 368' ' ' GLY . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.746 HD21 HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 332' ' ' LEU . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 339' ' ' GLU . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.466 ' HB1' ' NE1' ' A' ' 346' ' ' TRP . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.746 HE22 HD21 ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.426 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 378' ' ' PHE . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.535 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 364' ' ' LEU . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 384' ' ' THR . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.73 84.04 39.97 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.14 144.31 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.252 1.968 . . . . 0.0 111.373 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -79.21 129.44 34.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -89.69 136.61 32.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.5 m -73.08 150.51 42.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.382 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.327 179.533 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.52 144.92 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.779 2.319 . . . . 0.0 111.752 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.92 175.8 53.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -63.32 116.73 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 7.2 ttt -141.54 130.65 23.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.926 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -168.56 171.98 42.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.646 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.4 p -158.08 166.04 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.7 154.21 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.3 p -89.51 168.18 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.067 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 253' ' ' ALA . 59.6 t30 -77.82 115.94 17.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.693 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -142.2 -55.72 0.44 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.26 -43.33 95.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 250' ' ' ASN . . . -173.5 154.54 2.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.211 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.411 ' O ' ' OG1' ' A' ' 255' ' ' THR . 51.1 Cg_exo -51.29 -45.28 38.11 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.426 1.417 . . . . 0.0 111.925 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 254' ' ' PRO . 94.0 m -168.37 106.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 258' ' ' LEU . 72.2 m -73.44 -64.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.631 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 56.14 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 256' ' ' SER . 56.4 tp -160.69 110.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.043 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 260' ' ' ALA . 36.4 mmt180 -106.15 -9.68 16.82 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 259' ' ' ARG . . . 57.61 117.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.87 -39.77 95.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.615 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.37 135.9 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -88.7 -74.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.47 141.28 45.32 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.669 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -85.44 -12.91 50.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.435 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.64 -40.67 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.525 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -86.48 112.46 21.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.251 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.9 m -105.08 49.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.6 p -60.88 -35.37 76.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.46 143.99 54.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.736 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -85.08 152.85 23.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.624 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.528 ' HB3' HG11 ' A' ' 314' ' ' VAL . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.431 HD23 ' HG2' ' A' ' 312' ' ' LYS . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 370' ' ' LEU . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 322' ' ' TYR . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.532 ' HB2' HG13 ' A' ' 314' ' ' VAL . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' HD23 ' A' ' 290' ' ' LEU . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 311' ' ' ARG . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 368' ' ' GLY . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 323' ' ' ILE . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD2' HG11 ' A' ' 308' ' ' VAL . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 332' ' ' LEU . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.448 ' O ' ' NE2' ' A' ' 341' ' ' GLN . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 338' ' ' ASP . 0.7 OUTLIER -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.544 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 367' ' ' VAL . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.657 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.657 ' CZ ' HD11 ' A' ' 370' ' ' LEU . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 346' ' ' TRP . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 388' ' ' ILE . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 385' ' ' PRO . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -134.64 82.8 43.98 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.34 144.18 96.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 111.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -79.22 128.61 33.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.701 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.92 144.57 25.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.6 m -72.74 146.14 46.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.828 -179.793 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.655 0.265 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.586 ' HB3' HG11 ' A' ' 314' ' ' VAL . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 294' ' ' ILE . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 296' ' ' PHE . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.512 HD21 ' CZ ' ' A' ' 311' ' ' ARG . 11.3 p30 -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 281' ' ' PHE . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 368' ' ' GLY . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 320' ' ' ILE . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.481 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.481 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 388' ' ' ILE . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.518 HD21 ' ND2' ' A' ' 391' ' ' ASN . 1.0 OUTLIER -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.44 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 375' ' ' PHE . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.447 HD12 ' CE2' ' A' ' 378' ' ' PHE . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.498 ' NH2' ' OH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 350' ' ' ILE . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 346' ' ' TRP . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ASN . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.518 ' ND2' HD21 ' A' ' 347' ' ' ASN . 87.4 m-20 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.498 ' OH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 280' ' ' THR . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 276' ' ' GLU . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 15.5 m120 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.456 HG21 ' CE2' ' A' ' 296' ' ' PHE . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 294' ' ' ILE . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.646 HH11 HD22 ' A' ' 313' ' ' ASN . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . 0.646 HD22 HH11 ' A' ' 311' ' ' ARG . 97.1 m-20 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 314' ' ' VAL . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 366' ' ' ARG . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 368' ' ' GLY . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.56 HE21 ' CD ' ' A' ' 330' ' ' GLN . 65.2 tp60 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.56 ' CD ' HE21 ' A' ' 326' ' ' GLN . 89.7 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.419 HD22 ' N ' ' A' ' 342' ' ' ASN . 0.9 OUTLIER -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 381' ' ' VAL . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.457 HD11 ' CE1' ' A' ' 378' ' ' PHE . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.572 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 296' ' ' PHE . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 294' ' ' ILE . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 368' ' ' GLY . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 323' ' ' ILE . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.449 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 HE22 ' A' ' 341' ' ' GLN . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.585 HE21 ' CD ' ' A' ' 330' ' ' GLN . 62.8 tp60 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.585 ' CD ' HE21 ' A' ' 326' ' ' GLN . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.556 HE22 HD21 ' A' ' 324' ' ' LEU . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 388' ' ' ILE . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.571 ' NH1' HD22 ' A' ' 357' ' ' LEU . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.571 HD22 ' NH1' ' A' ' 349' ' ' ARG . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 364' ' ' LEU . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 367' ' ' VAL . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 344' ' ' ASN . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 280' ' ' THR . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 276' ' ' GLU . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.436 HD12 ' OE1' ' A' ' 326' ' ' GLN . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.567 ' C ' HD22 ' A' ' 310' ' ' LEU . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 309' ' ' GLU . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 314' ' ' VAL . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 368' ' ' GLY . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.436 ' OE1' HD12 ' A' ' 306' ' ' LEU . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 388' ' ' ILE . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.458 ' HB3' HD11 ' A' ' 380' ' ' LEU . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.482 ' HB2' HG11 ' A' ' 381' ' ' VAL . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 362' ' ' PRO . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 354' ' ' ASP . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 352' ' ' GLU . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.688 ' HG3' HD12 ' A' ' 350' ' ' ILE . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 364' ' ' LEU . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 346' ' ' TRP . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 344' ' ' ASN . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 . . . . . 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 294' ' ' ILE . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.456 HD11 HD21 ' A' ' 292' ' ' LEU . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 311' ' ' ARG . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 368' ' ' GLY . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 323' ' ' ILE . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.409 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 320' ' ' ILE . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 325' ' ' LEU . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 329' ' ' ASN . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 328' ' ' VAL . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.457 ' N ' ' OE1' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.4 OUTLIER -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 347' ' ' ASN . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.591 ' O ' HD12 ' A' ' 315' ' ' LEU . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 367' ' ' VAL . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 378' ' ' PHE . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 370' ' ' LEU . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 347' ' ' ASN . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.844 0.354 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.786 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.786 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 276' ' ' GLU . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.738 ' HB3' HG11 ' A' ' 314' ' ' VAL . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 18.5 m120 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 295' ' ' TYR . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 294' ' ' ILE . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.509 ' HB2' HG22 ' A' ' 314' ' ' VAL . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 281' ' ' PHE . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 366' ' ' ARG . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 323' ' ' ILE . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.474 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 340' ' ' ALA . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 383' ' ' ALA . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 378' ' ' PHE . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 364' ' ' LEU . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 381' ' ' VAL . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 345' ' ' TYR . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.437 HG22 HE21 ' A' ' 392' ' ' GLN . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . 0.437 HE21 HG22 ' A' ' 388' ' ' ILE . 8.7 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.605 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.605 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 280' ' ' THR . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 276' ' ' GLU . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 311' ' ' ARG . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 357' ' ' LEU . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.516 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 367' ' ' VAL . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.763 ' H ' HD12 ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 364' ' ' LEU . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.421 ' H ' ' HB2' ' A' ' 387' ' ' GLN . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 384' ' ' THR . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 294' ' ' ILE . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 292' ' ' LEU . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 368' ' ' GLY . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 323' ' ' ILE . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 320' ' ' ILE . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.573 ' HB3' HD11 ' A' ' 380' ' ' LEU . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 348' ' ' LEU . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.463 HD22 ' C ' ' A' ' 347' ' ' ASN . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.519 ' HB2' HG11 ' A' ' 381' ' ' VAL . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . 0.685 HD12 ' HG2' ' A' ' 362' ' ' PRO . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.428 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 350' ' ' ILE . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 364' ' ' LEU . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.518 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 346' ' ' TRP . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 391' ' ' ASN . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 280' ' ' THR . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 276' ' ' GLU . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 294' ' ' ILE . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.467 HD11 HD21 ' A' ' 292' ' ' LEU . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 368' ' ' GLY . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.746 HD21 HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 332' ' ' LEU . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 339' ' ' GLU . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.466 ' HB1' ' NE1' ' A' ' 346' ' ' TRP . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . 0.746 HE22 HD21 ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.426 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 378' ' ' PHE . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.535 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 364' ' ' LEU . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 384' ' ' THR . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 . . . . . 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.795 0.331 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.528 ' HB3' HG11 ' A' ' 314' ' ' VAL . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.431 HD23 ' HG2' ' A' ' 312' ' ' LYS . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 370' ' ' LEU . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 322' ' ' TYR . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.532 ' HB2' HG13 ' A' ' 314' ' ' VAL . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' HD23 ' A' ' 290' ' ' LEU . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 311' ' ' ARG . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 368' ' ' GLY . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 323' ' ' ILE . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD2' HG11 ' A' ' 308' ' ' VAL . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.564 HE21 ' CD ' ' A' ' 330' ' ' GLN . 69.0 tp60 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLN . . . . . 0.564 ' CD ' HE21 ' A' ' 326' ' ' GLN . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 332' ' ' LEU . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 367' ' ' VAL . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.657 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.657 ' CZ ' HD11 ' A' ' 370' ' ' LEU . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 346' ' ' TRP . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 388' ' ' ILE . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 385' ' ' PRO . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.07 -19.52 45.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.5 2.133 . . . . 0.0 111.189 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -157.54 -150.71 5.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -70.1 142.66 52.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.65 0.262 . . . . 0.0 110.295 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtt -64.57 -40.45 95.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.174 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.07 141.37 41.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 81.7 p -76.33 159.79 30.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.4 t 38.57 80.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.019 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.0 p -90.04 144.22 26.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.308 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -156.65 166.47 33.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.761 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.33 144.37 48.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.386 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -100.94 105.12 16.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -174.4 78.33 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.28 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.8 148.29 92.49 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.867 2.378 . . . . 0.0 111.821 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.4 m -61.57 -45.23 95.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 m -76.6 55.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.855 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.5 mt -76.39 149.33 36.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.312 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -65.47 -40.7 93.47 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.777 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -117.06 144.57 44.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 262' ' ' LEU . 0.2 OUTLIER -97.53 85.37 3.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.698 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 262' ' ' LEU . 9.4 mp 34.18 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.629 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -68.08 138.67 55.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.982 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -83.9 151.31 25.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.31 -66.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.623 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -161.9 79.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 55.68 36.47 27.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.7 t -71.77 145.39 48.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 87.5 p -158.71 158.64 34.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 110.901 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.16 -24.27 63.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -72.64 141.11 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -80.76 160.67 43.41 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.19 -47.7 23.16 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.386 2.057 . . . . 0.0 111.305 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 64.2 mt -67.51 -38.39 84.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 0.0 109.579 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' ALA . . . -57.47 -24.38 55.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.202 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 280' ' ' THR . 95.7 mt-10 -56.01 -48.97 74.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.715 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -71.53 -41.64 68.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.532 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -82.66 -51.71 7.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.23 -18.33 0.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.845 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 10.4 m -61.74 -34.49 75.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.243 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.586 ' HB3' HG11 ' A' ' 314' ' ' VAL . 17.1 m-85 -99.3 2.76 45.77 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 309' ' ' GLU . 78.4 p -80.86 -15.55 56.06 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.67 41.95 97.66 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -56.89 -40.55 76.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 109.99 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.85 -7.86 59.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.521 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -97.96 115.93 29.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.51 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 74.2 m -78.63 -8.28 58.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.145 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.17 12.97 28.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.06 142.08 57.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.8 mm? -80.95 132.86 35.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.741 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -80.87 154.11 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 294' ' ' ILE . 4.2 tt -147.26 137.06 23.02 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.251 0.548 . . . . 0.0 112.02 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.4 m-20 -120.45 152.15 38.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 296' ' ' PHE . 47.3 mm -127.52 151.49 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.272 0.558 . . . . 0.0 111.794 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -149.01 93.17 2.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 294' ' ' ILE . 0.2 OUTLIER -76.66 126.54 85.87 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.114 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.25 -31.38 7.61 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.771 1.648 . . . . 0.0 112.34 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -25.34 62.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.174 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 75.7 m -72.02 146.14 47.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -88.77 -9.29 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.953 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 7.9 t -123.26 67.24 34.83 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.86 -7.96 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.516 2.144 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 93.0 p -71.86 -4.19 26.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -111.85 80.72 3.12 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.487 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.82 157.52 31.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.377 2.051 . . . . 0.0 112.332 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.3 tt -92.49 121.08 33.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.013 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -110.84 116.53 31.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.216 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.83 159.4 23.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.701 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 282' ' ' SER . 94.9 mt-10 -107.69 122.41 46.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 290' ' ' LEU . 55.1 mt -123.57 149.8 44.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.707 0.289 . . . . 0.0 110.52 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 83.7 mtp180 -68.01 162.21 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.572 0.701 . . . . 0.0 110.9 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -78.86 -12.67 60.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.104 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.512 HD21 ' CZ ' ' A' ' 311' ' ' ARG . 11.3 p30 -106.14 -15.42 14.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 281' ' ' PHE . 33.2 m -80.48 146.95 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.632 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.464 ' O ' ' OE1' ' A' ' 318' ' ' GLU . 28.1 mt -75.31 173.88 10.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.752 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 368' ' ' GLY . 94.7 t -64.36 -40.46 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 24.2 p -39.86 -33.79 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.869 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 52.6 mp0 -70.55 -32.31 69.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.699 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.82 -56.06 16.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.61 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.2 tt -69.47 -36.66 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -50.42 -32.11 22.21 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.235 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 322' ' ' TYR . 41.7 t80 -71.07 -25.41 62.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 111.092 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 320' ' ' ILE . 16.2 tt -44.36 -31.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.039 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.97 -43.67 98.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.338 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.7 mp -63.97 -43.92 94.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.716 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.481 HE21 ' CD ' ' A' ' 330' ' ' GLN . 53.1 tt0 -68.33 -35.06 77.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.424 ' O ' ' N ' ' A' ' 331' ' ' GLN . 70.7 t80 -56.96 -47.79 79.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.19 -44.71 91.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.559 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.23 -43.83 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.567 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.481 ' CD ' HE21 ' A' ' 326' ' ' GLN . 88.6 mt-30 -92.39 -7.29 48.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.55 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 327' ' ' TYR . 87.0 mt-30 45.55 52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.368 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.25 127.38 31.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.032 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.8 t -71.55 -42.2 10.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.594 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 82.4 Cg_exo -43.55 124.86 4.48 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.909 1.073 . . . . 0.0 110.891 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.64 125.49 8.27 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.502 1.468 . . . . 0.0 112.623 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 93.8 mt -118.02 128.1 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.52 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 83.2 tt0 -65.17 147.75 52.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.148 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.437 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 15.2 t70 -69.29 -37.57 77.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.177 0.513 . . . . 0.0 110.746 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 92.7 mt-10 -76.75 -7.99 56.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.033 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.58 -9.45 59.63 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.01 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 338' ' ' ASP . 8.6 mp0 -64.41 -37.78 88.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -73.25 147.62 87.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.8 Cg_endo -70.72 -16.03 33.52 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.09 1.86 . . . . 0.0 111.811 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 388' ' ' ILE . 83.0 m-20 -66.12 -35.06 79.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.323 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -80.8 -39.49 26.64 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.5 m95 -128.77 164.09 23.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.518 HD21 ' ND2' ' A' ' 391' ' ' ASN . 1.0 OUTLIER -118.12 152.99 34.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.81 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 60.0 mt -109.13 121.6 45.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.44 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.9 ttm180 -113.57 142.35 46.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.374 0.607 . . . . 0.0 111.208 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 375' ' ' PHE . 20.3 tt -75.08 152.43 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.931 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.64 159.9 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.429 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -74.45 -179.63 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.4 -18.69 64.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.714 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -91.13 -2.5 57.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.443 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.2 7.52 85.0 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.58 148.25 48.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.8 mt -80.52 128.48 33.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.969 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.5 106.04 16.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.06 -16.14 44.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.08 -22.88 59.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.574 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -98.99 152.43 37.78 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.797 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.38 167.83 26.32 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.953 2.435 . . . . 0.0 112.35 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.37 114.82 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.665 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.447 HD12 ' CE2' ' A' ' 378' ' ' PHE . 37.8 mt -73.82 151.91 40.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.51 -152.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.927 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.498 ' NH2' ' OH ' ' A' ' 395' ' ' TYR . 68.3 ttt180 -58.96 -32.47 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 10.8 p -78.14 -21.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.674 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.49 101.46 1.56 Allowed Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -55.99 139.08 84.27 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 119.368 1.584 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.39 -41.8 98.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.55 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.9 p -74.68 -5.16 41.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.67 -46.02 91.93 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.463 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.37 -22.45 19.67 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 110.632 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.37 23.82 69.83 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.706 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 350' ' ' ILE . 8.3 m-85 -94.21 141.74 28.21 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.298 0.549 . . . . 0.0 110.438 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 293' ' ' ASN . 95.0 m-20 -107.58 23.83 13.84 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.573 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 378' ' ' PHE . . . -149.72 138.78 21.18 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.833 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 377' ' ' ALA . 56.5 m-85 -152.77 171.69 17.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -136.84 157.41 46.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 346' ' ' TRP . 30.5 tp -91.15 122.26 33.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -113.43 135.84 51.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.37 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.29 136.43 57.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.519 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -129.01 136.11 49.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.959 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.26 173.59 3.27 Favored Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.23 -40.22 61.1 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.967 1.778 . . . . 0.0 112.36 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 72.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -71.0 -39.23 72.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.134 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ASN . 96.7 mt -63.54 -43.07 98.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.598 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -59.47 -41.56 90.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.0 -40.12 83.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.518 ' ND2' HD21 ' A' ' 347' ' ' ASN . 87.4 m-20 -63.28 -42.19 99.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.979 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -78.84 -17.56 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.207 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.19 -45.59 92.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.84 81.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 110.158 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.498 ' OH ' ' NH2' ' A' ' 366' ' ' ARG . 92.7 t80 -115.43 92.34 32.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.256 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.76 136.02 64.22 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.12 1.88 . . . . 0.0 111.658 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -80.05 125.7 30.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.351 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.51 140.11 37.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.108 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 27.0 m -66.06 141.27 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 110.646 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.362 -179.793 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 52.6 Cg_exo -53.31 -42.46 65.09 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.537 2.158 . . . . 0.0 111.69 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 77.09 13.18 83.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -88.5 -12.24 43.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.734 0.302 . . . . 0.0 110.725 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 18.3 tpp -84.49 134.26 34.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.842 0.353 . . . . 0.0 110.415 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.57 6.73 73.01 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.4 m -59.81 -36.55 77.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.102 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.72 142.17 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.046 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 19.8 m -89.13 153.08 21.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -82.33 94.63 7.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -86.92 -4.4 59.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.988 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.03 144.06 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.226 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.79 77.47 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.049 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.81 145.22 99.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.52 2.147 . . . . 0.0 111.717 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.8 m -103.35 129.91 50.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.208 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 73.5 p -68.7 149.84 48.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.388 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.5 43.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.413 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 258' ' ' LEU . 8.9 mp -62.25 -41.75 98.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.553 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -103.24 130.5 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.354 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -160.17 -22.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 261' ' ' LEU . 8.2 mp -89.49 134.77 33.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.65 -5.68 58.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.406 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.72 127.13 31.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.87 145.07 48.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.615 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.49 140.51 31.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.077 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.73 -40.78 92.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 56.88 43.74 24.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.589 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.2 p -72.69 163.04 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.015 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.0 t -134.87 139.7 45.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.956 0.407 . . . . 0.0 110.801 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -82.74 91.75 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.673 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -101.19 134.5 44.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.308 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.58 178.15 18.77 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -54.22 -46.16 35.6 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.257 1.971 . . . . 0.0 111.797 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.0 mp -64.47 -39.41 93.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.784 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -56.25 -27.65 55.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.454 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 280' ' ' THR . 42.5 tp10 -56.64 -36.06 69.07 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.28 -43.93 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.469 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.45 -43.33 17.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -58.77 -27.66 65.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 276' ' ' GLU . 21.6 p -64.97 -34.42 78.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.041 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -104.92 7.6 34.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.448 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 309' ' ' GLU . 92.9 p -79.87 -3.65 48.87 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.626 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.21 51.9 29.27 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.42 -44.55 96.94 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.728 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.84 -18.0 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -87.08 111.17 20.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.651 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 89.4 p -78.73 -12.28 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.299 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -92.92 14.47 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.058 0.456 . . . . 0.0 110.725 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.93 152.91 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.1 mm? -71.09 143.8 50.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -110.87 135.7 51.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.813 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 306' ' ' LEU . 3.5 tt -129.78 137.09 50.32 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 376' ' ' ASP . 15.5 m120 -115.08 155.34 27.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.176 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.456 HG21 ' CE2' ' A' ' 296' ' ' PHE . 4.2 mm -128.26 153.28 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.276 0.56 . . . . 0.0 111.325 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -155.53 92.37 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.717 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 294' ' ' ILE . 0.0 OUTLIER -79.69 128.42 74.65 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.54 -21.06 19.85 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.521 1.48 . . . . 0.0 111.865 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.4 m -89.27 -14.73 35.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.364 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 13.8 m -70.72 144.35 51.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.966 0.412 . . . . 0.0 110.758 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 300' ' ' GLU . 57.0 mp0 -83.46 -11.78 57.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.954 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 44.9 p -129.12 65.29 73.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -9.45 24.37 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.696 2.264 . . . . 0.0 111.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.4 p -74.4 -2.81 27.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.327 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -106.63 92.92 7.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.23 158.23 26.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.064 1.843 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 292' ' ' LEU . 49.4 tp -85.59 121.47 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.423 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -109.47 108.44 18.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.6 158.63 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.109 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 282' ' ' SER . 71.0 mt-10 -115.24 116.89 29.07 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 2.2 pp -122.05 146.61 47.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.984 0.421 . . . . 0.0 111.277 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.646 HH11 HD22 ' A' ' 313' ' ' ASN . 9.5 mmm180 -65.02 158.33 25.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.927 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -79.79 -6.88 58.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.862 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.646 HD22 HH11 ' A' ' 311' ' ' ARG . 97.1 m-20 -102.33 -20.58 14.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 314' ' ' VAL . 13.4 m -79.49 149.88 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 121.506 0.669 . . . . 0.0 111.696 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 366' ' ' ARG . 13.7 mt -79.26 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.878 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 368' ' ' GLY . 98.3 t -61.58 -25.37 36.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.133 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -36.85 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.389 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -31.88 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -44.26 -61.31 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.2 tp -70.69 -30.43 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.1 83.16 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.386 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -71.84 -25.22 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.077 0.439 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.9 tp -44.29 -36.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.74 -42.91 99.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.723 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.26 -42.52 96.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.045 0.45 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.56 HE21 ' CD ' ' A' ' 330' ' ' GLN . 65.2 tp60 -63.52 -39.6 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.139 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 331' ' ' GLN . 61.6 t80 -60.65 -50.0 75.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.391 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.18 -37.66 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 0.0 111.223 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.96 -41.76 98.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.56 ' CD ' HE21 ' A' ' 326' ' ' GLN . 89.7 mt-30 -104.12 -3.46 24.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.054 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 327' ' ' TYR . 88.6 mt-30 44.81 27.26 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.859 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 333' ' ' VAL . 3.6 tp -126.19 -153.5 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 332' ' ' LEU . 21.1 t 57.94 122.85 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.829 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -40.46 154.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.625 1.55 . . . . 0.0 111.584 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.94 148.52 40.61 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.152 1.901 . . . . 0.0 111.777 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 45.3 mm -114.02 130.1 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.122 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -60.32 151.46 27.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.993 0.425 . . . . 0.0 110.69 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.62 -34.58 78.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.79 -35.07 74.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.069 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.15 -8.93 59.39 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.951 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.97 -39.72 94.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.419 HD22 ' N ' ' A' ' 342' ' ' ASN . 0.9 OUTLIER -68.45 142.45 94.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.9 Cg_endo -70.46 -17.44 34.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.198 1.932 . . . . 0.0 112.183 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.47 -35.65 79.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.325 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -69.93 -40.23 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.489 ' O ' ' O ' ' A' ' 343' ' ' PRO . 62.8 m95 -115.58 164.4 14.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.174 0.511 . . . . 0.0 110.723 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 62.3 m-20 -117.74 148.43 42.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.937 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 11.9 tp -109.89 122.9 48.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 381' ' ' VAL . 40.5 ttm180 -115.49 139.47 50.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.049 0.452 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.4 tt -84.64 139.5 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.612 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.71 157.66 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.826 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.56 162.67 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.993 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.66 -17.05 45.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -91.18 -2.49 57.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.8 8.63 82.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.92 127.21 32.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.486 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.9 mp -74.64 139.91 43.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -71.51 141.3 50.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.78 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.59 -6.95 59.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -71.44 -16.83 62.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' A' ' 361' ' ' PHE . 75.1 t80 53.27 55.29 13.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.453 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 361' ' ' PHE . 56.8 Cg_endo -69.46 155.52 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.77 2.314 . . . . 0.0 112.611 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.35 115.9 26.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.13 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 373' ' ' PHE . 61.2 mt -111.81 142.7 43.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 13.7 t0 -174.01 -162.76 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 111.119 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 93.9 mtt-85 -59.8 -37.05 78.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.005 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.16 -2.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.199 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -114.14 91.21 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.9 128.54 24.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.937 1.758 . . . . 0.0 112.104 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.457 HD11 ' CE1' ' A' ' 378' ' ' PHE . 57.2 tp -65.43 -40.87 93.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.857 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.7 p -60.72 -33.35 72.77 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -61.65 -36.93 82.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.788 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . 0.575 ' CZ ' ' CD2' ' A' ' 364' ' ' LEU . 97.7 m-85 -69.08 -24.74 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.851 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 65.19 21.83 68.51 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.022 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -110.18 146.67 35.14 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.508 0.654 . . . . 0.0 110.675 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 293' ' ' ASN . 14.8 p-10 -111.01 19.64 18.27 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.238 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -146.86 140.68 25.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 87.7 m-85 -152.98 170.67 19.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.44 150.09 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 13.0 tp -91.26 131.08 37.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.2 p -117.01 138.87 46.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.544 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -63.77 129.59 40.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.39 0.614 . . . . 0.0 111.659 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -112.96 95.39 5.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.677 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.31 0.46 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.033 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.32 -40.19 78.71 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.03 1.82 . . . . 0.0 112.302 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -59.15 -48.73 80.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.88 -37.73 82.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.68 -43.65 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.06 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -60.12 -42.67 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.27 -41.35 90.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.077 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -65.19 -42.55 93.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 110.547 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.61 -40.55 80.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.652 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.09 90.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.97 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.05 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.47 80.34 45.6 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.53 144.29 99.46 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.418 2.079 . . . . 0.0 111.883 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -90.89 128.2 36.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -118.16 141.96 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.194 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 26.3 m -72.11 142.52 49.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.17 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.911 -1.043 . . . . 0.0 110.642 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.94 -38.68 86.43 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.723 2.282 . . . . 0.0 111.997 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 79.94 9.88 86.22 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 50.12 74.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 60.2 mtm -64.19 -40.57 96.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.007 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.5 130.85 2.27 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 37.2 p -156.47 162.31 39.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 249' ' ' SER . 35.0 m -63.38 -45.22 98.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.75 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.514 ' N ' HG23 ' A' ' 248' ' ' VAL . 23.8 m -90.47 154.52 19.58 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 110.896 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 52.5 t30 54.02 37.89 27.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.853 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.22 144.99 32.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -63.01 -41.99 99.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.122 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.13 147.68 60.43 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.793 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.84 150.4 83.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.969 1.779 . . . . 0.0 112.009 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -98.57 53.82 1.03 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.543 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 72.4 m -101.49 -1.6 32.7 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.85 59.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.891 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 258' ' ' LEU . 8.3 mp -81.12 -6.03 58.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.376 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -62.98 -43.51 98.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.756 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -170.64 96.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.1 128.48 47.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.178 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 82.5 mt -104.89 130.47 53.03 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.474 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -139.57 143.93 37.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -85.27 102.28 13.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.236 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.4 169.35 4.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.871 0.367 . . . . 0.0 110.822 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 65.5 t30 54.96 68.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.865 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 84.1 p -59.96 -40.94 90.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.9 p -79.0 166.49 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -119.8 134.38 55.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.007 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -71.61 138.55 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.572 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -104.46 172.1 20.01 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.3 -51.59 7.25 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.383 2.056 . . . . 0.0 111.018 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.07 -39.55 93.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.586 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -58.13 -28.47 64.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.629 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 280' ' ' THR . 84.7 tt0 -55.21 -31.65 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.51 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -91.39 -46.89 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -82.72 -43.97 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -27.71 69.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 276' ' ' GLU . 16.0 m -62.73 -35.59 80.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.193 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -101.46 7.02 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 309' ' ' GLU . 32.0 t -79.52 -3.04 44.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.445 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 47.67 53.29 13.5 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -62.89 -44.7 95.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 0.0 110.691 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.86 -14.54 59.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.739 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 81.6 tt0 -88.78 116.21 26.88 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 97.9 p -78.27 -11.23 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 97.3 m-20 -90.84 12.24 20.01 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.964 0.411 . . . . 0.0 110.375 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.54 147.26 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.713 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.0 mm? -78.43 127.97 32.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.143 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -82.33 145.25 30.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 tt -140.89 138.92 34.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.187 0.518 . . . . 0.0 112.113 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 376' ' ' ASP . 94.2 m-20 -122.4 155.84 35.23 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.064 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 296' ' ' PHE . 42.3 mm -130.06 155.03 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.089 0.471 . . . . 0.0 111.205 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 294' ' ' ILE . 92.4 m-85 -156.72 90.55 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.81 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 294' ' ' ILE . 96.7 m-85 -68.6 126.23 92.53 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.01 -34.84 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.725 1.616 . . . . 0.0 112.023 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 4.7 t -70.69 -24.84 62.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.539 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.3 t -73.34 136.27 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.725 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.33 -25.47 64.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.04 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 86.1 p -109.75 76.09 0.89 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 304' ' ' LYS . 59.5 Cg_endo -72.16 -10.49 25.93 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.959 1.773 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -72.63 13.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.253 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 302' ' ' PRO . 56.6 mmtt -111.37 80.73 2.7 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.526 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.17 157.77 30.07 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.376 2.051 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 5.4 tt -112.49 115.9 29.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.431 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -107.43 114.81 29.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.12 159.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.109 0.481 . . . . 0.0 111.177 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 282' ' ' SER . 96.5 mt-10 -103.69 118.03 35.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.058 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.82 148.59 49.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.154 0.502 . . . . 0.0 111.75 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -71.26 160.37 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.712 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.47 -7.07 58.17 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.066 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -101.14 -21.5 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 5.2 m -74.04 147.35 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.159 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 8.2 mt -80.22 177.09 9.2 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.475 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 368' ' ' GLY . 77.9 t -65.47 -43.02 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.829 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 10.3 t -43.6 -42.73 5.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.498 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.724 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -46.85 -60.47 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 323' ' ' ILE . 8.1 tp -71.24 -37.64 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.561 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -47.71 -31.1 7.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.8 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.449 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 31.6 t80 -70.52 -25.12 62.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.322 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 320' ' ' ILE . 6.6 tp -43.28 -37.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.49 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.556 HD21 HE22 ' A' ' 341' ' ' GLN . 47.1 mt -62.25 -43.55 98.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.67 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 22.1 mt -64.17 -42.73 96.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.442 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.585 HE21 ' CD ' ' A' ' 330' ' ' GLN . 62.8 tp60 -66.27 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.897 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 331' ' ' GLN . 82.2 t80 -60.0 -48.29 82.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.59 -44.09 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -62.95 -42.67 99.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.013 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.585 ' CD ' HE21 ' A' ' 326' ' ' GLN . 97.8 mt-30 -98.6 -11.06 22.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.891 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 327' ' ' TYR . 98.8 mm-40 49.93 11.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.797 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 330' ' ' GLN . 34.5 mt -103.92 -162.15 0.88 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.8 t 61.33 133.41 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.01 145.25 73.11 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.455 1.437 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.92 140.16 79.04 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.512 1.474 . . . . 0.0 112.271 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.39 132.49 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -52.1 142.83 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.386 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.5 -41.73 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.041 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.38 -8.17 58.15 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.327 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.78 28.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.556 HE22 HD21 ' A' ' 324' ' ' LEU . 82.7 mt-30 -70.89 -41.09 71.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 344' ' ' ASN . 34.5 t-20 -56.01 118.01 18.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.334 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 346' ' ' TRP . 87.8 Cg_exo -44.31 -15.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.614 1.543 . . . . 0.0 111.681 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 388' ' ' ILE . 89.8 m-20 -64.07 -34.18 77.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.507 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -94.36 -37.75 11.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.277 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.417 ' O ' ' O ' ' A' ' 343' ' ' PRO . 38.9 m95 -121.49 167.6 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.238 0.542 . . . . 0.0 110.755 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -118.7 152.47 36.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.316 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.34 121.09 44.47 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.571 ' NH1' HD22 ' A' ' 357' ' ' LEU . 55.7 ttp180 -113.24 142.24 46.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.244 0.545 . . . . 0.0 110.997 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.3 tp -82.65 140.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.94 159.69 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.858 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -77.07 164.61 25.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 37.6 p-10 -63.38 -20.6 65.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -81.48 -4.23 55.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.31 9.87 81.12 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.67 148.09 31.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 110.272 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.571 HD22 ' NH1' ' A' ' 349' ' ' ARG . 83.2 mt -76.21 146.1 39.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.578 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 359' ' ' GLU . 67.1 t0 -72.08 132.18 43.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 361' ' ' PHE . 80.5 mm-40 -65.05 -39.38 93.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.775 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -71.04 -21.22 62.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.016 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 359' ' ' GLU . 73.2 m-85 50.62 60.01 15.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.36 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.63 165.3 20.43 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 111.755 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -121.57 115.05 22.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.039 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 364' ' ' LEU . 11.0 mp -91.18 142.76 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.062 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 364' ' ' LEU . 65.0 m-20 -157.7 -168.94 2.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.608 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.96 -31.67 70.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 367' ' ' VAL . 11.6 p -78.76 -5.02 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.075 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -122.47 91.15 0.45 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -52.16 133.32 46.78 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.318 1.345 . . . . 0.0 110.909 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -63.41 -41.93 98.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.261 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 t -62.3 -18.35 61.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.376 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.12 -45.39 93.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.387 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -69.4 -24.94 63.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 72.27 12.6 76.47 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.312 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -100.72 145.68 28.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.621 0.71 . . . . 0.0 110.541 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 293' ' ' ASN . 99.7 m-20 -104.18 21.66 16.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.832 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.483 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.19 142.8 30.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 110.417 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 92.6 m-85 -151.18 168.84 23.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -143.01 154.51 44.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.588 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.4 tp -91.17 130.32 37.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.151 0.501 . . . . 0.0 110.15 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.1 p -114.89 135.21 55.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -65.01 142.13 58.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.138 0.494 . . . . 0.0 111.247 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -135.52 141.03 45.19 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.268 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 p -99.37 152.36 37.76 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.1 -32.49 2.94 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.993 1.795 . . . . 0.0 112.509 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -57.08 -48.92 77.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.697 0.284 . . . . 0.0 110.63 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.48 -29.67 69.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.253 0.549 . . . . 0.0 110.391 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 344' ' ' ASN . 29.3 mm -66.35 -41.39 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.345 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -54.42 -43.15 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.442 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.36 -40.23 62.26 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.72 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.86 -44.09 90.84 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.999 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -66.88 -39.3 87.45 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.167 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.49 95.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.972 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.02 -40.49 94.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.127 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -133.65 80.46 56.3 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.371 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.65 144.28 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.464 2.11 . . . . 0.0 112.046 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -95.99 121.39 37.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.983 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -97.51 108.7 21.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.44 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 36.7 t -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.596 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 52.8 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.711 179.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.92 155.55 53.06 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.805 2.337 . . . . 0.0 112.026 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.85 -21.5 1.14 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . 0.498 ' ND1' ' N ' ' A' ' 244' ' ' HIS . 0.0 OUTLIER -150.89 160.75 43.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.785 0.326 . . . . 0.0 110.508 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 99.4 mmm -65.18 -40.79 94.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 58.72 104.21 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.6 t -70.31 141.67 52.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.754 0.311 . . . . 0.0 110.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 m -122.34 133.3 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.344 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.9 p -89.32 163.82 15.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -65.61 -38.88 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.02 -34.03 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.53 -10.74 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.319 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -134.32 77.06 61.21 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.31 146.56 97.19 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 65.7 p -129.24 158.28 39.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.0 t -67.67 143.95 55.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 258' ' ' LEU . . . -157.81 -5.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 257' ' ' ALA . 82.3 mt -62.63 -42.21 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.274 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -139.08 137.76 36.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -164.17 51.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.095 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.96 -41.81 99.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.536 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.76 125.14 42.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 264' ' ' HIS . 84.3 tt0 -159.99 151.18 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.474 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 263' ' ' GLU . 85.9 m-70 57.93 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -84.17 -6.22 59.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.377 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -46.97 153.44 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.737 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.55 -40.23 96.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.03 89.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.302 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 21.0 m -72.55 146.77 46.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -156.0 -32.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.04 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.79 164.96 15.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -124.06 176.04 16.88 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.35 -46.8 30.76 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.074 1.849 . . . . 0.0 111.84 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 274' ' ' LEU . 11.2 mp -63.54 -41.51 98.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.316 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -60.88 -24.54 66.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.986 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 280' ' ' THR . 0.5 OUTLIER -55.05 -30.74 60.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.19 -38.94 9.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -82.54 -44.03 16.39 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.837 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -60.81 -24.78 66.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.314 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 276' ' ' GLU . 16.7 p -63.07 -27.87 69.69 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -97.98 7.23 46.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.07 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 35.2 t -78.53 -6.21 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.936 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 37.75 65.9 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -63.77 -42.62 97.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.41 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -12.2 59.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -97.07 107.52 20.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.6 p -78.6 -12.85 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.725 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.23 8.66 31.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.084 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.19 145.34 53.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -72.38 131.65 42.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.739 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -95.06 137.83 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 306' ' ' LEU . 7.2 tt -130.67 135.79 48.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 376' ' ' ASP . 98.9 m-20 -113.78 153.82 28.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.721 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 5.0 mm -127.06 134.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.86 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.39 136.07 37.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.988 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.24 145.62 40.69 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.691 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.97 -28.88 57.77 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.163 1.909 . . . . 0.0 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 78.0 p -89.84 -13.62 36.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.5 p 44.97 52.73 8.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.789 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.53 -37.82 80.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.096 0.474 . . . . 0.0 110.11 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 48.4 t -146.12 71.87 13.37 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.56 -4.44 12.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.72 2.28 . . . . 0.0 111.831 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.0 p -68.66 -17.07 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.068 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -125.58 79.69 67.13 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.005 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.88 161.22 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.489 2.126 . . . . 0.0 111.891 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.436 HD12 ' OE1' ' A' ' 326' ' ' GLN . 6.5 tp -74.91 106.08 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -106.35 106.95 17.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.103 0.477 . . . . 0.0 109.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 22.0 m -153.59 159.06 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.464 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.567 ' C ' HD22 ' A' ' 310' ' ' LEU . 96.8 mt-10 -114.72 115.0 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 309' ' ' GLU . 4.1 mm? -114.65 165.17 13.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.122 0.487 . . . . 0.0 110.992 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -71.58 160.93 31.81 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.894 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.24 -25.31 39.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.891 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -74.65 -22.26 59.0 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 314' ' ' VAL . 4.8 m -74.76 143.9 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.642 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 50.7 mt -82.13 -179.45 7.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.479 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 368' ' ' GLY . 93.9 t -61.73 -45.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 88.1 p -44.79 -29.22 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.318 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.38 -33.99 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.376 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -50.06 -56.99 8.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 15.5 tt -72.31 -26.86 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -60.81 -36.81 92.57 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.712 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.82 -37.3 81.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.076 0.438 . . . . 0.0 111.635 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.2 tt -42.99 -27.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.02 -42.96 99.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.22 -43.71 97.33 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.453 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.436 ' OE1' HD12 ' A' ' 306' ' ' LEU . 87.5 mt-30 -88.27 -18.04 29.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -60.01 -48.97 79.52 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.833 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 88.8 t -67.66 -44.19 86.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.919 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 329' ' ' ASN . 54.2 t-20 -66.28 -42.65 88.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.549 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 331' ' ' GLN . 98.7 mm-40 -87.09 -10.95 51.59 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 330' ' ' GLN . 51.7 tt0 38.63 54.42 1.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.937 0.399 . . . . 0.0 110.865 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.5 mt -52.04 141.84 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.763 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.62 -60.81 9.16 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.41 127.4 22.2 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.577 1.518 . . . . 0.0 110.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.63 140.93 24.3 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.798 1.666 . . . . 0.0 112.762 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 46.7 mm -118.23 127.09 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.428 ' O ' ' OE1' ' A' ' 341' ' ' GLN . 81.8 mt-10 -74.07 152.9 39.84 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.08 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -67.65 -21.84 65.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.31 -11.41 38.09 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.331 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -77.84 -6.57 54.64 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.692 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 337' ' ' GLU . 10.5 mp0 -64.78 -41.11 96.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.062 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 344' ' ' ASN . 20.7 m-80 -77.84 119.5 77.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.953 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 346' ' ' TRP . 84.9 Cg_exo -47.36 -9.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.753 1.635 . . . . 0.0 111.937 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 388' ' ' ILE . 98.6 m-20 -65.85 -18.66 65.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -101.64 -29.35 11.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.63 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.458 ' HB3' HD11 ' A' ' 380' ' ' LEU . 80.1 m95 -131.39 169.83 15.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 0.0 110.884 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.427 ' ND2' ' OE1' ' A' ' 387' ' ' GLN . 26.0 m-20 -118.14 152.66 35.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.59 120.85 43.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.482 ' HB2' HG11 ' A' ' 381' ' ' VAL . 58.5 ttp180 -114.69 140.26 48.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.096 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 362' ' ' PRO . 96.5 mt -74.69 152.68 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.271 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.47 142.09 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 354' ' ' ASP . 82.3 tt0 -80.01 160.88 25.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.172 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -60.94 -34.61 74.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.557 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 352' ' ' GLU . 95.7 m-20 -75.56 -6.89 52.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.314 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.5 70.08 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -73.92 151.42 40.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.782 0.325 . . . . 0.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.69 148.49 46.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -79.2 118.06 20.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 359' ' ' GLU . 1.3 pm0 -72.84 -8.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.05 -19.89 61.76 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 50.36 60.23 15.3 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.688 ' HG3' HD12 ' A' ' 350' ' ' ILE . 85.5 Cg_endo -75.86 158.89 38.64 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.706 2.271 . . . . 0.0 112.222 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -125.55 115.59 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.414 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 364' ' ' LEU . 10.8 mp -106.56 152.42 23.72 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.584 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 368' ' ' GLY . 39.4 p30 -157.17 179.66 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.0 111.563 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -59.52 -38.96 82.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.231 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.34 -6.19 8.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.495 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.16 98.82 1.13 Allowed Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.78 23.5 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.597 1.531 . . . . 0.0 112.05 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.61 -41.03 93.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.72 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 43.5 m -62.29 -14.25 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.269 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -59.22 -45.7 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -73.51 -25.61 60.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 73.56 23.06 77.78 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.646 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -91.34 143.88 26.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.202 0.525 . . . . 0.0 110.616 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 293' ' ' ASN . 28.0 p30 -104.7 9.44 35.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -144.88 144.73 31.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 111.135 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 88.4 m-85 -149.81 165.56 32.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.838 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.99 154.3 48.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 346' ' ' TRP . 32.0 tp -91.15 125.98 36.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.7 p -119.97 149.74 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.997 0.427 . . . . 0.0 110.099 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.03 129.82 41.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.975 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -120.26 100.25 7.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.754 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 175.54 2.46 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.733 -0.387 . . . . 0.0 109.978 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.21 -37.0 87.73 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.198 1.932 . . . . 0.0 112.713 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.21 78.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 110.856 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.427 ' OE1' ' ND2' ' A' ' 347' ' ' ASN . 85.9 mt-30 -67.75 -36.79 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 344' ' ' ASN . 89.3 mt -63.07 -42.51 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -56.04 -43.9 78.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.243 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -40.19 76.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -64.81 -39.59 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -53.51 -42.63 67.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.691 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.77 -38.66 91.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.854 0.359 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -83.1 -9.24 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CD2' ' OD1' ' A' ' 344' ' ' ASN . 90.2 t80 -119.13 87.96 35.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.83 146.52 97.36 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.164 1.909 . . . . 0.0 111.729 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -96.05 122.18 38.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.754 0.312 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.71 143.01 27.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.1 m -72.04 144.2 48.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.243 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.697 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.25 153.01 67.03 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.682 2.255 . . . . 0.0 111.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 98.61 161.79 30.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -58.65 -45.78 88.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 110.365 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 98.5 mtp -84.77 142.26 29.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.381 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -58.56 -45.72 94.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.4 p -162.13 154.54 19.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.18 -46.31 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.876 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 12.6 m -99.15 150.38 22.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.101 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -83.63 151.34 25.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.415 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.16 143.02 54.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.17 118.26 31.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.32 75.4 0.67 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.261 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.77 143.14 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.451 2.1 . . . . 0.0 111.0 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 38.3 m -68.41 119.84 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.053 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 258' ' ' LEU . 6.6 m -95.42 -2.07 49.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.426 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.52 16.53 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 256' ' ' SER . 55.6 tp -60.66 -43.11 98.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.281 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -72.5 141.67 48.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.06 90.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.61 128.77 36.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.543 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.86 138.95 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 263' ' ' GLU . 57.6 mp0 -74.2 116.46 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.195 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -67.99 -40.24 83.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.809 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.88 141.55 31.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 267' ' ' ASN . 10.7 tm-20 -119.41 143.54 47.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.175 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.48 ' N ' ' CD ' ' A' ' 266' ' ' GLU . 23.0 m120 -84.57 98.82 10.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.569 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 85.6 p -81.99 167.44 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.426 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.6 p -152.22 155.66 38.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.953 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -143.3 104.05 4.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -159.77 173.52 15.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -179.03 -177.79 47.82 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -54.4 -49.47 16.8 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.232 1.955 . . . . 0.0 111.538 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.52 -34.86 78.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -50.81 -25.1 4.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.175 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -55.0 -48.94 72.67 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.809 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.21 -41.06 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.101 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -82.43 -48.64 10.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -51.95 -17.76 1.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.826 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 26.3 m -59.82 -21.26 60.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.44 6.43 45.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.394 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -80.56 -9.51 59.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.354 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 286' ' ' GLU . . . 45.76 56.18 6.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -60.28 -45.14 94.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -13.73 60.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 283' ' ' GLY . 97.3 mt-10 -113.71 105.51 13.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 10.5 t -76.67 -6.21 51.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -90.31 16.46 8.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.469 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -56.07 146.22 23.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.951 0.405 . . . . 0.0 110.48 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 290' ' ' LEU . 2.9 mm? -79.16 131.04 36.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.632 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -88.39 145.97 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 294' ' ' ILE . 5.8 tt -141.81 135.06 29.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.227 0.537 . . . . 0.0 112.233 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 376' ' ' ASP . 96.0 m-20 -117.24 152.62 34.44 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.987 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.456 HD11 HD21 ' A' ' 292' ' ' LEU . 37.9 mm -125.63 132.79 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.946 0.403 . . . . 0.0 111.618 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 379' ' ' ALA . 81.2 m-85 -136.62 132.42 35.04 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.51 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -90.5 154.01 46.18 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.1 -28.64 65.42 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.137 1.891 . . . . 0.0 110.669 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 86.3 p -86.95 -20.36 27.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.097 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 17.4 t 41.36 64.69 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.691 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.73 -35.51 67.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.401 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -139.28 67.72 39.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.624 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.59 -18.43 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.424 2.082 . . . . 0.0 111.677 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 78.7 p -69.62 -14.08 62.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.205 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.491 ' NZ ' ' OE1' ' A' ' 330' ' ' GLN . 81.0 tttt -130.1 79.58 72.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.58 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.09 158.63 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.414 2.076 . . . . 0.0 111.743 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 53.5 tp -75.26 107.33 7.28 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -103.74 106.45 16.96 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.44 161.55 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.369 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -106.18 121.07 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 290' ' ' LEU . 69.7 mt -114.96 139.25 49.98 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' HB2' HG13 ' A' ' 314' ' ' VAL . 96.9 mtt180 -72.02 155.98 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.247 0.546 . . . . 0.0 110.012 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -70.13 -7.95 45.71 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -104.17 -20.85 13.67 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 311' ' ' ARG . 34.7 m -77.26 142.11 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.272 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 315' ' ' LEU . 3.2 mm? -75.44 -176.68 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.886 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 368' ' ' GLY . 97.5 t -65.57 -43.7 94.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.558 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -48.06 -33.04 7.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.017 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 55.1 mp0 -69.49 -25.84 64.26 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.051 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.58 -52.89 61.6 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 323' ' ' ILE . 9.3 tp -72.48 -31.48 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.785 0.326 . . . . 0.0 111.805 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -58.28 -38.21 89.52 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.896 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.409 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 25.1 t80 -64.2 -27.44 69.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 111.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 320' ' ' ILE . 9.3 tt -52.85 -23.54 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.629 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.19 -42.19 99.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.894 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 325' ' ' LEU . 11.2 mp -62.89 -43.09 99.73 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.44 -40.66 77.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.375 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -60.53 -50.42 73.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.24 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 329' ' ' ASN . 14.6 p -70.74 -40.41 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.467 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 328' ' ' VAL . 99.1 m-20 -63.5 -41.31 98.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.491 ' OE1' ' NZ ' ' A' ' 304' ' ' LYS . 76.5 mt-30 -104.43 -10.75 17.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 52.81 11.82 0.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.829 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 330' ' ' GLN . 50.8 mt -93.04 -165.76 1.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.54 0.209 . . . . 0.0 110.545 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.8 t 66.11 128.77 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.376 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -38.74 154.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.051 1.834 . . . . 0.0 111.748 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.87 126.25 11.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.698 1.599 . . . . 0.0 111.763 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.51 129.31 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 16.3 pt-20 -56.26 140.13 45.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.492 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.52 -20.36 66.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.013 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -73.49 -22.49 60.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.25 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -80.87 -11.96 59.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.847 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.457 ' N ' ' OE1' ' A' ' 341' ' ' GLN . 2.2 mp0 -62.15 -40.53 96.26 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.971 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.58 148.3 79.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 346' ' ' TRP . 42.0 Cg_endo -69.41 -13.85 36.22 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.319 2.012 . . . . 0.0 111.732 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.12 -35.13 79.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.311 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.84 -40.68 15.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 343' ' ' PRO . 16.8 m95 -118.99 170.05 9.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.4 OUTLIER -117.23 162.1 18.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 109.935 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 347' ' ' ASN . 4.1 mm? -108.18 123.09 48.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -120.33 139.08 53.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.433 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 20.0 tt -89.23 139.96 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.918 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.44 159.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.694 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -76.82 -175.62 3.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.32 0.581 . . . . 0.0 110.828 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -66.29 -34.11 77.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.457 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.92 -4.17 54.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.096 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 86.38 9.63 75.56 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.786 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.29 145.44 54.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.54 144.3 46.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.964 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -96.14 116.11 28.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.521 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.57 -5.36 3.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.341 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.98 -18.95 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.57 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 361' ' ' PHE . 65.1 t80 38.17 58.68 5.0 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.629 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.79 164.05 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.676 2.25 . . . . 0.0 111.435 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -117.76 114.53 23.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.959 0.409 . . . . 0.0 109.966 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.38 148.78 32.29 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 40.1 t0 -171.35 -170.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.772 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.591 ' O ' HD12 ' A' ' 315' ' ' LEU . 64.7 ttt180 -57.8 -37.61 74.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.197 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.544 ' O ' HG22 ' A' ' 367' ' ' VAL . 5.2 p -79.95 -6.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -108.75 100.83 1.45 Allowed Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.28 130.29 35.02 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.712 1.608 . . . . 0.0 112.774 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 378' ' ' PHE . 69.5 tp -64.31 -42.44 96.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.927 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 68.4 m -63.86 -5.57 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.77 -48.84 80.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.603 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -86.82 -23.87 25.18 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.014 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 75.59 11.31 84.5 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.912 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -81.16 142.79 32.9 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.242 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 293' ' ' ASN . 45.8 p30 -104.06 16.25 26.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.007 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -145.07 139.33 27.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 370' ' ' LEU . 52.9 m-85 -149.19 171.39 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 295' ' ' TYR . . . -141.47 154.32 45.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.961 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 347' ' ' ASN . 3.0 mt -90.54 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.04 140.58 47.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -64.72 121.72 15.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.715 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -101.62 124.56 47.48 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.18 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 158.51 47.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.64 -32.15 89.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.21 1.94 . . . . 0.0 111.939 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.813 0.34 . . . . 0.0 110.812 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.87 -37.14 21.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 90.6 mt -62.87 -43.12 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.82 -42.15 92.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.701 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.82 -48.43 66.25 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.964 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -64.05 -41.42 97.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.463 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.07 -40.28 84.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.391 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.92 95.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.331 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.24 85.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.434 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.497 ' CG ' ' O ' ' A' ' 395' ' ' TYR . 3.6 t80 -116.93 85.43 17.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.634 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.81 144.99 92.48 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.205 1.937 . . . . 0.0 111.397 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.78 118.12 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.663 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.85 141.92 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.496 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 73.6 m -63.43 143.47 57.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.465 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.574 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 242' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 241' ' ' GLY . 51.3 Cg_exo -54.0 -41.07 78.3 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.635 2.223 . . . . 0.0 112.331 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -169.04 -178.7 40.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 245' ' ' MET . 54.4 t-80 -80.88 139.22 36.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.627 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . 0.511 ' O ' ' CE1' ' A' ' 244' ' ' HIS . 83.8 mtp -81.36 133.67 35.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.132 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.1 158.19 27.74 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.3 t -72.8 140.76 47.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.669 0.271 . . . . 0.0 110.391 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.15 -46.5 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 85.6 p -89.79 162.96 15.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -156.92 170.6 22.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.048 0.451 . . . . 0.0 111.266 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 56.95 170.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.112 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.65 -43.99 97.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 49.48 60.47 15.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.11 150.39 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.726 2.284 . . . . 0.0 112.202 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 256' ' ' SER . 34.0 p -67.53 -32.23 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 255' ' ' THR . 2.9 p 81.81 23.88 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.212 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.1 -10.26 59.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 258' ' ' LEU . 10.6 mp -62.14 -41.53 98.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -67.49 127.24 31.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -74.46 136.41 42.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.761 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 45.2 tp -120.14 -60.6 1.68 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.101 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.39 -42.88 98.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.54 151.36 32.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.454 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -98.78 127.09 44.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.744 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -80.24 116.44 20.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.645 ' CD ' ' H ' ' A' ' 266' ' ' GLU . 2.6 pm0 -83.73 160.82 21.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -63.18 -40.16 96.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.6 t -149.47 153.34 37.11 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.815 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.1 p -151.37 162.12 41.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.31 -40.94 90.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.497 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 272' ' ' GLY . 51.4 t-20 -74.96 140.74 43.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.721 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.786 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -150.74 -178.61 25.76 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -53.35 -47.14 29.03 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.14 1.893 . . . . 0.0 111.63 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.18 -40.95 97.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.786 ' HB3' ' H ' ' A' ' 272' ' ' GLY . . . -56.11 -36.96 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 81.3 tt0 -58.02 -43.2 86.57 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.406 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.36 -41.4 89.56 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.94 -43.23 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -57.04 -23.53 47.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 276' ' ' GLU . 20.6 p -65.15 -20.56 66.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.738 ' HB3' HG11 ' A' ' 314' ' ' VAL . 65.3 m-85 -103.49 5.27 36.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.583 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 309' ' ' GLU . 71.8 m -83.4 -16.56 45.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.62 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 46.81 52.48 11.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.81 -44.53 96.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.483 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.03 60.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.98 114.73 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.356 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 21.5 t -69.35 -15.77 63.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.103 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 288' ' ' ASN . 46.0 p30 -85.36 4.01 37.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.97 139.32 57.68 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 290' ' ' LEU . 2.5 mm? -84.32 129.26 34.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.13 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.02 149.65 35.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.63 140.75 30.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.925 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 376' ' ' ASP . 18.5 m120 -120.52 154.89 34.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.68 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 295' ' ' TYR . 9.3 mm -125.21 152.37 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 294' ' ' ILE . 75.1 m-85 -150.59 85.82 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.873 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -79.66 126.6 80.2 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.25 -28.24 8.94 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.585 1.524 . . . . 0.0 111.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 38.8 t -83.34 -13.13 55.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.356 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 15.3 m -72.19 147.97 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.62 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.48 -15.43 42.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.239 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 17.2 m -123.22 64.9 28.05 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 -14.01 27.92 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.432 2.088 . . . . 0.0 111.615 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 83.5 p -78.6 6.05 9.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -122.76 82.53 49.03 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.626 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.12 151.85 83.61 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.81 2.34 . . . . 0.0 112.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 42.9 tp -86.52 117.18 25.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.661 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -106.47 106.6 17.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.5 m -143.11 163.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 282' ' ' SER . 95.3 mt-10 -109.48 119.61 39.97 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 290' ' ' LEU . 88.9 mt -113.36 141.9 46.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.509 ' HB2' HG22 ' A' ' 314' ' ' VAL . 95.7 mtt180 -67.68 153.78 42.94 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.417 0.627 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.2 -14.04 59.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.941 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.04 -20.94 18.91 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 281' ' ' PHE . 35.7 m -88.93 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.37 0.605 . . . . 0.0 111.209 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 366' ' ' ARG . 25.4 mt -71.49 -178.02 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.09 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 319' ' ' ALA . 96.7 t -66.98 -40.79 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.327 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 77.6 p -39.8 -29.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.456 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 318' ' ' GLU . 53.3 mp0 -73.68 -31.4 63.42 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.403 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -51.02 -55.04 19.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 323' ' ' ILE . 17.7 tt -68.0 -38.73 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -44.64 -32.82 3.07 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.106 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.474 ' O ' ' CD2' ' A' ' 322' ' ' TYR . 28.7 t80 -68.28 -25.57 65.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.961 0.381 . . . . 0.0 111.184 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.7 tt -51.89 -26.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.464 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 324' ' ' LEU . 3.8 mm? -61.61 -43.26 99.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.4 mp -64.69 -40.89 96.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.648 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -63.8 -37.57 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 331' ' ' GLN . 79.7 t80 -60.39 -51.99 67.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.763 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.94 -44.1 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.821 0.343 . . . . 0.0 111.168 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.4 -41.17 98.74 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.78 -11.37 17.62 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 327' ' ' TYR . 51.6 mt-30 52.75 11.58 0.21 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.151 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.93 179.87 5.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.797 0.332 . . . . 0.0 110.418 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 334' ' ' PRO . 40.0 t 58.78 111.65 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.393 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 333' ' ' VAL . 77.2 Cg_exo -40.59 165.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.675 1.583 . . . . 0.0 112.146 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.02 137.85 77.25 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.57 1.513 . . . . 0.0 111.587 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 80.0 mt -110.68 129.77 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 340' ' ' ALA . 12.8 pt-20 -57.77 141.99 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.354 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 338' ' ' ASP . 33.6 p-10 -65.34 -32.95 74.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.285 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.43 ' N ' ' OD1' ' A' ' 338' ' ' ASP . 96.6 mt-10 -64.71 -14.68 59.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.435 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.452 ' CB ' ' NE1' ' A' ' 346' ' ' TRP . . . -79.31 -19.08 51.3 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.084 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 341' ' ' GLN . 13.1 mp0 -63.81 -38.18 90.15 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -50.33 112.04 2.55 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.475 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 346' ' ' TRP . 71.6 Cg_exo -47.46 -30.03 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.76 1.64 . . . . 0.0 112.337 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -64.53 -34.98 79.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.035 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 383' ' ' ALA . 13.0 m-85 -70.32 -40.13 74.34 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.467 ' O ' ' O ' ' A' ' 343' ' ' PRO . 40.2 m95 -128.08 151.47 49.14 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.809 0.338 . . . . 0.0 110.501 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.54 151.73 37.31 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.254 0.549 . . . . 0.0 111.117 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.79 124.77 51.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -122.01 159.29 27.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.077 0.465 . . . . 0.0 111.786 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.1 tt -74.73 147.25 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.477 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.7 143.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -81.33 -178.68 7.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.74 -19.78 65.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.641 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -97.15 2.0 50.57 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.17 16.49 76.4 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.2 159.25 18.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 89.1 mt -103.14 129.05 49.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -94.43 106.69 18.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.407 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.7 -27.74 66.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.505 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.84 -28.62 65.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.642 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.24 152.95 48.5 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.39 159.87 48.27 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.487 2.124 . . . . 0.0 112.71 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -105.06 116.43 31.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.404 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 378' ' ' PHE . 48.6 mt -64.29 152.23 41.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 19.5 t0 -163.19 -153.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.063 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 61.0 ttm-85 -58.56 -36.85 74.57 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.95 -13.0 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -111.59 100.02 1.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.8 136.55 72.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.85 -39.95 94.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.212 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 93.2 p -69.15 -5.89 25.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.591 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.87 -46.6 88.78 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.273 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -102.33 -21.8 14.24 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.841 0.353 . . . . 0.0 110.334 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 69.57 29.41 71.46 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.93 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.81 142.57 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 293' ' ' ASN . 91.2 m-20 -99.1 11.42 39.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.77 142.0 26.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.972 0.415 . . . . 0.0 111.196 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.411 ' CE2' HD12 ' A' ' 364' ' ' LEU . 43.9 m-85 -152.25 166.01 33.1 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.317 0.579 . . . . 0.0 110.756 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.85 49.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.4 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -93.43 128.86 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 381' ' ' VAL . 2.3 m -105.03 130.26 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -65.36 121.85 15.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 345' ' ' TYR . . . -101.61 133.25 46.58 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.8 p -80.43 157.01 73.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.948 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -49.63 -39.63 46.6 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.426 1.417 . . . . 0.0 111.558 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.49 -37.46 80.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.555 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.437 HG22 HE21 ' A' ' 392' ' ' GLN . 96.1 mt -62.99 -42.6 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.94 -38.91 80.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -38.47 76.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.18 -46.74 85.68 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.091 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . 0.437 HE21 HG22 ' A' ' 388' ' ' ILE . 8.7 pt20 -71.6 -37.01 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.445 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.6 91.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.33 80.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.91 81.77 45.16 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.632 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.87 142.24 92.94 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.418 2.079 . . . . 0.0 111.733 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . 0.426 ' CE2' ' O ' ' A' ' 398' ' ' LYS . 86.5 t80 -132.27 143.2 49.73 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.473 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.426 ' O ' ' CE2' ' A' ' 397' ' ' PHE . 50.6 mtmt -70.3 139.52 52.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.9 t -129.3 142.02 50.95 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.694 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.852 -179.733 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.76 145.96 52.72 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.774 2.316 . . . . 0.0 111.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 161.3 153.94 7.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -67.64 -40.8 84.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 110.188 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.13 144.01 29.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.622 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.28 -23.84 0.28 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.6 m 45.41 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.288 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.6 t -128.11 134.18 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 18.5 m -89.72 142.68 27.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.277 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 92.2 m-20 -148.13 -81.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -61.92 -24.8 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.27 -11.16 8.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.66 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.85 75.57 35.97 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.395 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.59 147.12 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.814 2.343 . . . . 0.0 112.27 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 43.7 p -85.45 134.15 34.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 258' ' ' LEU . 38.4 t -156.44 169.11 25.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.156 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -74.78 35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.568 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 258' ' ' LEU . 9.1 mp 58.62 37.84 25.25 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.953 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -84.07 143.06 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.812 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -105.41 53.76 0.71 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.15 -41.74 99.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 83.7 mt -100.71 -164.35 1.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 264' ' ' HIS . 97.6 mt-10 52.24 89.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 263' ' ' GLU . 96.1 m-70 47.72 179.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.63 133.16 37.94 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.491 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -94.52 128.06 40.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -87.79 103.43 15.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.344 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.9 m -78.12 -7.06 56.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 70.5 m -72.48 146.56 46.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.381 . . . . 0.0 110.691 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -173.11 88.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -74.09 142.1 45.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.605 ' H ' ' CB ' ' A' ' 275' ' ' ALA . . . -97.68 166.37 22.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.46 -41.32 77.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.196 1.93 . . . . 0.0 111.174 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.47 -18.22 36.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.901 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.605 ' CB ' ' H ' ' A' ' 272' ' ' GLY . . . -63.83 -26.77 68.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.132 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 280' ' ' THR . 14.1 tm-20 -56.99 -48.3 78.75 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.91 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -68.9 -41.74 77.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.171 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -84.13 -46.22 12.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 275' ' ' ALA . . . -57.11 -27.43 61.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 276' ' ' GLU . 17.1 p -64.55 -34.92 79.37 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.51 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.54 7.42 35.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.591 0.234 . . . . 0.0 110.809 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 309' ' ' GLU . 37.5 t -79.05 -2.66 41.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 110.339 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.81 38.57 88.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -60.32 -44.08 95.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.438 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.66 -11.09 59.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -104.71 115.25 30.0 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.96 0.409 . . . . 0.0 110.574 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 93.0 p -78.21 -5.44 51.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.711 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -87.09 6.57 31.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.945 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.65 142.4 55.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.6 mm? -81.54 141.35 33.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -85.43 143.23 28.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.251 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.5 tt -138.82 134.94 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.805 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 376' ' ' ASP . 95.2 m-20 -118.44 154.24 32.8 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.141 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 38.7 mm -129.09 135.41 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.302 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.76 117.82 17.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.123 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -93.66 126.79 48.42 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.15 -24.31 14.88 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.63 1.553 . . . . 0.0 112.539 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 96.8 p -86.38 -11.76 51.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.139 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.4 m -75.94 145.15 40.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.14 -7.32 48.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.443 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 25.1 t -132.07 66.46 77.55 Favored Pre-proline 0 N--CA 1.463 0.183 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.86 -5.87 17.98 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.595 2.196 . . . . 0.0 111.638 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 96.8 p -69.79 -2.91 13.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -113.62 81.01 5.22 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.636 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.42 158.9 22.66 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.191 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 52.1 tp -83.92 107.24 16.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -101.07 106.7 18.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 m -141.18 158.23 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.1 mt-10 -100.9 117.85 35.77 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.01 141.84 47.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.206 0.527 . . . . 0.0 110.94 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 311' ' ' ARG . 1.7 mmp_? -74.27 160.07 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.791 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 pttm -80.49 -5.72 57.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.364 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -94.46 -20.67 19.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.965 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.87 152.15 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.108 0 CA-C-O 121.137 0.494 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.14 175.62 8.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.39 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 318' ' ' GLU . 90.2 t -62.34 -43.84 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' NH1' ' A' ' 366' ' ' ARG . 23.9 m -39.84 -24.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.163 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 316' ' ' VAL . 76.9 tt0 -71.48 -30.02 65.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.69 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.76 -51.05 41.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 323' ' ' ILE . 10.6 tp -68.61 -38.63 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -56.67 -39.62 86.55 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.509 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.84 -24.81 66.97 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.61 -0.347 . . . . 0.0 111.274 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 320' ' ' ILE . 10.1 tt -51.03 -33.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.48 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.56 -41.93 98.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.417 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.2 -43.88 96.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.771 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -68.07 -35.34 78.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.723 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 331' ' ' GLN . 53.8 t80 -59.77 -49.19 78.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.235 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.99 -45.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -64.49 -43.1 95.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.712 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -93.07 -10.08 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 327' ' ' TYR . 49.4 tt0 41.59 51.85 3.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 109.984 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 333' ' ' VAL . 4.4 tp -152.29 -144.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 332' ' ' LEU . 25.7 t 58.97 126.42 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.3 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.51 153.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.589 1.526 . . . . 0.0 111.435 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.97 128.73 12.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.185 1.923 . . . . 0.0 112.214 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 95.4 mt -118.79 128.28 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.815 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 340' ' ' ALA . 22.4 pt-20 -64.12 149.56 47.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 0.0 110.543 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -64.05 -36.68 84.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.942 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' CG ' ' A' ' 345' ' ' TYR . 96.0 mt-10 -61.15 -21.99 64.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 337' ' ' GLU . . . -91.18 -6.21 53.82 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.058 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -65.79 -41.01 92.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.574 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 342' ' ' ASN . 1.0 OUTLIER -71.92 146.31 90.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 346' ' ' TRP . 58.0 Cg_endo -68.7 -16.94 42.6 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.591 2.194 . . . . 0.0 112.866 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -66.17 -35.32 80.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.475 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 35.2 m-85 -77.04 -39.16 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.471 ' O ' ' O ' ' A' ' 343' ' ' PRO . 28.8 m95 -117.64 169.72 9.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.476 0.655 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 383' ' ' ALA . 77.3 m-20 -118.25 148.02 42.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.896 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 8.2 tt -113.0 127.54 56.26 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -131.43 142.11 49.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.517 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.3 tt -78.47 148.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.87 156.97 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.275 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.1 172.26 14.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.88 -16.26 62.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 109.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.85 -3.21 56.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.108 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 83.51 5.97 87.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.61 137.3 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 357' ' ' LEU . 7.3 mp -79.31 134.62 36.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -105.36 107.23 18.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.135 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.12 -38.47 66.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.657 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -70.84 -27.43 63.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -82.32 121.45 78.5 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.194 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.67 152.09 23.06 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.491 1.461 . . . . 0.0 112.345 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.43 25.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.3 mm? -69.03 153.16 44.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 32.9 t0 -163.92 -153.5 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.546 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.516 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 53.8 ttm-85 -59.71 -36.91 77.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 367' ' ' VAL . 9.6 p -79.6 -7.38 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.993 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -125.33 93.6 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.91 132.69 48.31 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.957 1.771 . . . . 0.0 112.153 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 371' ' ' SER . 0.1 OUTLIER -63.92 -41.93 97.53 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.996 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.763 ' H ' HD12 ' A' ' 370' ' ' LEU . 78.1 p -67.09 -33.48 75.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -61.97 -44.22 97.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 364' ' ' LEU . 78.7 m-85 -72.74 -23.94 60.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.51 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 85.95 -2.62 87.7 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.339 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.14 138.08 36.84 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.982 0.891 . . . . 0.0 109.968 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 293' ' ' ASN . 38.4 p30 -109.65 20.58 17.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.136 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -142.91 142.7 31.78 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.451 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' ALA . 95.8 m-85 -154.69 171.82 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.075 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -146.56 148.43 32.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 12.8 tp -91.79 126.37 36.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.073 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.1 136.13 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -63.8 129.44 40.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.406 0.622 . . . . 0.0 111.192 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 347' ' ' ASN . . . -105.15 146.84 28.65 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.421 ' H ' ' HB2' ' A' ' 387' ' ' GLN . 0.7 OUTLIER -116.12 167.57 10.11 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.38 -40.4 62.19 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.225 1.284 . . . . 0.0 112.101 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -64.5 -47.05 80.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 110.292 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.421 ' HB2' ' H ' ' A' ' 384' ' ' THR . 88.2 mt-30 -66.97 -39.82 87.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.522 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.24 -42.13 95.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.46 -46.74 85.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.27 -41.46 73.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 110.26 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 395' ' ' TYR . 50.7 t30 -63.55 -36.9 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.485 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -53.59 -45.08 69.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.931 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.49 88.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -82.29 -6.16 59.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 391' ' ' ASN . 75.7 t80 -97.9 107.14 38.69 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.08 145.36 92.46 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.466 1.444 . . . . 0.0 111.649 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -86.84 121.94 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.897 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -81.29 133.29 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 13.5 m -73.13 148.86 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.226 179.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.18 151.7 76.74 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.814 2.343 . . . . 0.0 111.956 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -63.17 -37.13 94.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.21 127.09 31.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 0.0 110.502 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 65.4 mtt -129.79 156.27 44.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.029 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.3 33.53 39.47 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 70.8 m -59.54 -36.12 75.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.592 0.234 . . . . 0.0 110.521 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.6 t -83.76 120.86 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 58.5 m -130.35 154.52 47.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.64 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.15 -40.19 96.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -137.96 151.95 48.45 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.57 -42.8 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.015 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . 43.88 58.29 12.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.17 143.97 73.33 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.611 2.207 . . . . 0.0 111.872 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 256' ' ' SER . 27.1 m -161.72 -61.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.409 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 255' ' ' THR . 3.5 m 56.14 130.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.282 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.44 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 82.0 mt -73.35 141.47 47.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.288 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -67.27 -40.96 86.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.952 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -127.28 150.71 49.44 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 81.1 mt -63.17 -40.04 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.717 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 262' ' ' LEU . 10.7 mp -76.02 138.23 40.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.055 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 264' ' ' HIS . 81.9 tt0 -150.81 -20.85 0.22 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . 0.405 ' H ' ' H ' ' A' ' 263' ' ' GLU . 96.1 m-70 -79.08 148.24 32.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.637 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.88 150.65 44.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.37 -3.85 23.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.11 107.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.614 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 56.6 m -63.47 -42.48 98.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 69.4 m -129.66 152.83 48.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -101.77 128.93 47.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -94.81 132.78 39.22 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.979 0.418 . . . . 0.0 110.546 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 275' ' ' ALA . . . -102.12 173.63 23.48 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.59 -51.71 9.82 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.6 mp -68.62 -37.73 79.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 279' ' ' ALA . . . -54.97 -30.63 59.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.893 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.45 -22.29 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.165 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.44 ' O ' ' CE1' ' A' ' 281' ' ' PHE . 21.4 t-20 -102.15 -45.36 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.5 -43.71 16.85 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 275' ' ' ALA . . . -63.26 -26.3 68.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 28.1 p -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.538 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 277' ' ' ASN . 13.4 m-85 -102.16 7.26 40.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.564 0.221 . . . . 0.0 110.562 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 309' ' ' GLU . 75.3 m -79.7 -5.52 55.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.791 0.329 . . . . 0.0 110.405 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.74 35.8 86.17 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.38 -44.72 89.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.643 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.39 -12.84 60.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.651 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 288' ' ' ASN . 82.9 tt0 -102.53 116.66 33.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.462 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 84.8 p -78.58 -8.16 58.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 286' ' ' GLU . 95.8 m-20 -90.48 11.02 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.665 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.19 145.34 56.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.7 mm? -76.21 138.17 40.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.48 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -88.66 144.02 26.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.647 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 294' ' ' ILE . 5.0 tt -140.66 135.06 31.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.973 0.416 . . . . 0.0 111.418 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 376' ' ' ASP . 99.1 m-20 -118.84 152.99 35.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.555 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 292' ' ' LEU . 42.5 mm -129.75 134.2 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.312 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -138.24 129.37 27.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -82.1 148.95 61.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.369 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.3 -31.09 81.89 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.807 1.671 . . . . 0.0 110.678 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 84.2 p -84.44 -15.96 44.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.225 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.0 t 35.61 73.74 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.835 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -86.92 -28.39 22.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.006 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 10.4 t -141.0 65.15 22.2 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.35 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.97 -16.43 40.85 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.425 2.083 . . . . 0.0 111.979 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 74.9 p -69.9 -18.53 63.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.403 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -123.33 80.55 53.01 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.63 161.09 28.04 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.509 2.139 . . . . 0.0 111.763 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.66 108.96 15.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.184 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.23 107.91 19.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.23 159.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 111.212 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 282' ' ' SER . 97.7 mt-10 -108.73 123.33 48.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 68.5 mt -119.11 141.42 48.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.009 0.433 . . . . 0.0 111.366 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -74.36 166.43 23.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.66 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -79.27 -11.94 59.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.614 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -97.63 -22.09 16.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.334 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.1 138.29 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.029 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 315' ' ' LEU . 7.2 mp -75.12 -179.62 4.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.938 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 368' ' ' GLY . 84.0 t -63.16 -45.06 99.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 366' ' ' ARG . 9.6 p -42.6 -25.86 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.097 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 316' ' ' VAL . 40.0 tp10 -67.02 -34.17 77.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.115 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -50.94 -56.43 12.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 323' ' ' ILE . 12.9 tt -69.02 -38.58 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 320' ' ' ILE . . . -42.62 -33.21 1.47 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.446 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -76.16 -24.84 54.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 320' ' ' ILE . 13.0 tt -50.8 -31.24 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.553 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.57 -43.82 98.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.983 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.4 mp -63.6 -42.7 98.23 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.425 ' O ' ' CB ' ' A' ' 330' ' ' GLN . 98.8 mm-40 -80.44 -19.45 46.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.443 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -54.0 52.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.47 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.23 -47.17 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.237 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.76 -43.31 84.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 326' ' ' GLN . 38.7 tt0 -77.55 -10.79 59.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.6 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 53.44 40.78 31.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.65 133.08 41.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 334' ' ' PRO . 1.4 t -83.01 -38.83 0.77 Allowed Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.85 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 333' ' ' VAL . 51.8 Cg_exo -53.14 140.09 61.36 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.615 1.543 . . . . 0.0 111.638 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.83 129.1 11.33 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.053 1.835 . . . . 0.0 112.137 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 44.4 mm -118.52 126.67 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -73.75 145.35 45.17 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.221 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.65 -19.36 64.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -91.17 -17.89 25.36 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.96 0.2 32.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.553 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -62.58 -44.95 95.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.38 149.01 83.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 346' ' ' TRP . 63.5 Cg_endo -72.22 -12.87 28.11 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.12 1.88 . . . . 0.0 111.908 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.34 -35.74 80.01 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.558 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -71.27 -40.26 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.573 ' HB3' HD11 ' A' ' 380' ' ' LEU . 54.4 m95 -117.89 171.55 7.99 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.219 0.533 . . . . 0.0 110.929 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 348' ' ' LEU . 42.6 m-20 -116.49 147.23 41.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.631 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.463 HD22 ' C ' ' A' ' 347' ' ' ASN . 3.3 mm? -108.64 123.18 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.519 ' HB2' HG11 ' A' ' 381' ' ' VAL . 75.8 ttt180 -121.94 138.98 54.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . 0.685 HD12 ' HG2' ' A' ' 362' ' ' PRO . 96.7 mt -77.21 144.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.128 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.8 153.75 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -75.59 163.4 27.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.57 -32.66 58.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.905 0.383 . . . . 0.0 109.991 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.89 -5.14 47.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.44 62.71 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -77.39 149.9 35.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 357' ' ' LEU . 3.2 mm? -74.12 143.51 45.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.76 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.428 ' C ' HH11 ' A' ' 349' ' ' ARG . 67.2 t0 -88.6 110.47 20.94 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.354 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.23 -21.31 63.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -70.52 -27.8 64.46 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.899 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 66.4 t80 52.08 70.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 350' ' ' ILE . 15.0 Cg_exo -66.4 150.76 84.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.987 2.458 . . . . 0.0 112.089 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -104.58 115.31 30.11 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 365' ' ' ASP . 43.1 mt -108.21 -145.79 0.4 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.38 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 364' ' ' LEU . 27.8 t0 99.74 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.17 0.919 . . . . 0.0 110.724 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.518 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 96.0 mtt-85 -60.58 -33.21 72.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.032 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 8.0 m -79.69 -2.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.088 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -118.63 93.19 0.56 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.24 129.48 31.48 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.872 1.715 . . . . 0.0 111.4 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.77 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.598 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 69.3 m -58.49 -37.91 76.54 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.58 -39.77 92.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -69.45 -24.53 63.82 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.994 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 62.77 -1.9 1.51 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.384 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -80.33 137.62 36.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.259 0.53 . . . . 0.0 110.311 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 293' ' ' ASN . 97.7 m-20 -106.33 20.02 19.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.992 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.446 ' C ' ' CD1' ' A' ' 378' ' ' PHE . . . -145.46 144.68 30.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.435 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 377' ' ' ALA . 97.4 m-85 -154.15 168.81 25.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -139.08 153.68 48.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.154 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 346' ' ' TRP . 36.0 tp -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.6 p -121.64 141.06 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -64.58 120.07 11.66 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 384' ' ' THR . . . -75.51 -124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.523 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 383' ' ' ALA . 11.1 m -168.24 135.9 1.78 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.038 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -44.81 -43.53 14.88 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.322 1.348 . . . . 0.0 112.257 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.98 92.23 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.885 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -72.38 -34.1 67.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.862 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.5 -43.26 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.62 -40.78 97.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.759 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.1 -45.05 78.41 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.782 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 391' ' ' ASN . 8.0 m120 -63.29 -40.82 98.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.451 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -64.73 -37.76 88.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.15 96.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.068 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.39 85.08 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CD2' ' CD ' ' A' ' 366' ' ' ARG . 37.9 t80 -134.05 77.64 61.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-O 120.648 0.261 . . . . 0.0 110.743 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.43 144.37 99.51 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.476 2.117 . . . . 0.0 111.709 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -88.63 124.58 34.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.01 142.35 41.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 47.5 t -71.11 140.17 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.321 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.607 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.32 -37.17 88.62 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.582 2.188 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -174.82 175.74 46.99 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -65.36 -40.89 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.667 0.27 . . . . 0.0 110.51 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 40.3 tpp -90.17 131.77 35.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -83.02 97.17 1.96 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 t -68.69 -17.4 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.764 0.316 . . . . 0.0 110.798 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.85 -44.42 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 21.5 t -122.82 148.07 45.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.822 0.344 . . . . 0.0 110.32 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.64 141.05 30.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.976 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 48.14 74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.393 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -81.05 141.9 33.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.028 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -155.9 57.31 1.49 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.003 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.81 -23.29 62.74 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.341 2.027 . . . . 0.0 111.352 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.5 p -137.18 161.53 35.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.8 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 30.3 p -74.88 155.26 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.273 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.9 -27.76 10.02 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.744 0.306 . . . . 0.0 110.571 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.91 -42.41 99.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.478 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -76.41 139.88 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -168.23 -10.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 262' ' ' LEU . 87.3 mt -84.36 117.52 23.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 261' ' ' LEU . 79.8 mt 51.66 113.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -64.79 -36.11 83.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.531 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -79.63 131.36 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.791 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.75 -41.58 99.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -76.61 157.23 32.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.726 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -88.01 106.56 18.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 55.3 m -127.32 27.4 5.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.3 p -72.45 158.62 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.078 0.466 . . . . 0.0 111.059 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 -16.77 42.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.64 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -71.8 120.81 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.073 0.463 . . . . 0.0 110.99 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -97.87 171.85 26.47 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.58 -47.57 23.12 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.114 1.876 . . . . 0.0 111.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 274' ' ' LEU . 10.9 mp -66.32 -39.0 88.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.384 0.612 . . . . 0.0 109.504 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -55.24 -26.94 42.86 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.405 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 280' ' ' THR . 80.0 tt0 -59.85 -49.48 77.53 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -64.47 -40.55 95.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.448 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -81.77 -36.51 28.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -62.05 -23.62 66.58 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 276' ' ' GLU . 19.6 p -63.76 -33.59 76.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.667 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.17 4.39 44.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.91 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.5 m -80.6 -15.75 55.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 33.27 86.78 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.37 -34.65 78.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.6 -16.07 60.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.313 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -113.22 118.1 33.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.091 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 34.5 t -68.31 -10.79 57.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.4 16.34 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.62 149.15 50.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.334 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 290' ' ' LEU . 6.6 mp -82.92 127.0 33.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.548 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -81.69 150.01 28.22 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 294' ' ' ILE . 2.8 tt -151.97 143.06 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.463 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -127.45 153.73 45.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.972 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.467 HD11 HD21 ' A' ' 292' ' ' LEU . 43.7 mm -129.97 147.99 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.039 0.447 . . . . 0.0 111.412 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -147.59 95.3 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.584 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 296' ' ' PHE . 0.3 OUTLIER -75.48 133.23 74.4 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.195 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 -31.07 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.561 1.507 . . . . 0.0 111.7 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 32.5 t -74.54 -25.89 59.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 27.6 t -67.82 141.04 56.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.709 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -92.33 -8.78 44.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.77 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.8 t -120.26 72.12 18.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.857 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.81 -10.69 23.44 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.364 2.042 . . . . 0.0 111.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 86.2 p -68.75 -11.91 60.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -113.76 80.95 5.39 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 120.39 0.138 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.14 161.4 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.695 2.263 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 46.0 tp -85.17 107.77 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -100.21 106.31 17.98 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.1 m -142.3 159.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.46 117.76 33.29 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.4 mp -113.43 154.35 27.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -68.21 151.29 47.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.38 -34.83 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.562 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -91.21 8.99 33.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.63 135.83 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.81 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 315' ' ' LEU . 3.0 mm? -63.98 172.82 2.12 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.57 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 368' ' ' GLY . 92.3 t -68.38 -24.36 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.77 -45.34 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.844 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.08 -20.41 64.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.36 9.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.619 ' O ' HG22 ' A' ' 323' ' ' ILE . 11.0 tt -79.62 -24.56 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -57.33 -40.34 91.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.366 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.32 -25.37 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.806 0.336 . . . . 0.0 111.252 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.6 tt -49.3 -28.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.319 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.746 HD21 HE22 ' A' ' 341' ' ' GLN . 35.2 mt -61.13 -44.09 97.88 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.92 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 325' ' ' LEU . 10.5 mp -65.11 -43.2 92.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.338 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.53 -37.26 71.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 331' ' ' GLN . 90.4 t80 -58.4 -50.28 74.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.881 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.87 -44.03 89.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -66.13 -43.54 86.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.037 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.59 -10.21 35.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 327' ' ' TYR . 85.8 mt-30 46.0 54.08 8.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.694 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 332' ' ' LEU . 11.0 mp -53.85 138.26 36.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.006 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 334' ' ' PRO . 41.2 t -63.46 -54.07 46.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.93 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 333' ' ' VAL . 13.4 Cg_endo -54.01 127.64 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.38 1.387 . . . . 0.0 111.371 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.3 135.99 15.55 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.719 1.613 . . . . 0.0 112.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 97.3 mt -118.42 131.15 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.67 141.06 51.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.044 0.449 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.63 -22.3 64.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.801 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 339' ' ' GLU . 2.5 pp20? -91.02 -14.48 31.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.466 ' HB1' ' NE1' ' A' ' 346' ' ' TRP . . . -80.47 -15.47 56.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.515 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . 0.746 HE22 HD21 ' A' ' 324' ' ' LEU . 84.6 mt-30 -65.02 -40.14 94.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.01 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -49.02 110.19 1.44 Allowed Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.226 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 346' ' ' TRP . 75.8 Cg_exo -46.69 -27.6 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.633 1.556 . . . . 0.0 112.416 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -65.29 -35.39 80.86 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -70.64 -40.52 73.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 343' ' ' PRO . 64.1 m95 -121.13 166.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.43 0.633 . . . . 0.0 111.303 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -118.56 152.91 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.3 127.48 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.426 ' HB2' HG11 ' A' ' 381' ' ' VAL . 41.3 ttm180 -124.01 145.64 49.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.514 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.04 140.68 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.225 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 143.34 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 352' ' ' GLU . 1.0 OUTLIER -86.79 175.66 8.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -66.5 -21.4 66.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.308 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -79.55 -6.13 56.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.829 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 77.53 18.71 77.34 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -99.38 116.71 32.17 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.7 mp -79.7 134.44 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.969 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 110.67 23.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.453 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -81.58 -13.53 57.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.567 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.88 -19.28 61.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.537 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -94.97 152.25 39.44 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.463 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.89 161.45 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.429 2.086 . . . . 0.0 111.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -97.96 115.11 27.49 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 378' ' ' PHE . 24.2 mt -70.78 153.37 42.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 366' ' ' ARG . 17.7 t70 -160.38 -155.94 0.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.535 ' H ' ' CG ' ' A' ' 365' ' ' ASP . 87.4 mtm180 -58.61 -34.6 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.965 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -85.97 -7.05 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.787 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -110.44 98.54 1.09 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -53.38 133.23 52.22 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.258 1.529 . . . . 0.0 111.722 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.01 -41.28 99.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.008 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.0 t -67.19 -12.8 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.32 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -57.52 -47.34 82.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.572 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -101.11 -23.59 14.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 68.46 28.23 73.34 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.109 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.94 141.09 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.999 0.9 . . . . 0.0 109.995 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -99.03 12.45 35.98 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.562 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -147.92 139.2 23.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.827 0.346 . . . . 0.0 110.679 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 364' ' ' LEU . 51.1 m-85 -148.37 169.2 20.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 110.646 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -133.37 153.1 51.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.395 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 24.2 tp -91.99 124.85 36.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 349' ' ' ARG . 2.3 p -117.33 137.47 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 109.806 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.8 pptp? -64.09 141.53 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.909 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -131.29 103.25 6.35 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 384' ' ' THR . 0.1 OUTLIER -66.94 175.47 1.44 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.225 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.85 -38.1 77.97 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.243 1.962 . . . . 0.0 112.672 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.4 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.6 -32.83 58.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.67 -43.17 98.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.274 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -60.48 -37.39 80.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.209 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.36 -48.19 76.46 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.269 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.2 -41.2 97.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.674 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -64.52 -40.63 95.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.205 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.15 93.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.27 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.51 91.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -134.73 84.04 39.97 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.888 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.14 144.31 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.252 1.968 . . . . 0.0 111.373 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -79.21 129.44 34.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -89.69 136.61 32.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.443 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.5 m -73.08 150.51 42.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.382 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.327 179.533 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.52 144.92 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.779 2.319 . . . . 0.0 111.752 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -76.92 175.8 53.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -63.32 116.73 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' MET . . . . . . . . . . . . . 7.2 ttt -141.54 130.65 23.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.926 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -168.56 171.98 42.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.646 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.4 p -158.08 166.04 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.7 154.21 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.3 p -89.51 168.18 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.067 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 253' ' ' ALA . 59.6 t30 -77.82 115.94 17.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.693 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -142.2 -55.72 0.44 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.26 -43.33 95.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 250' ' ' ASN . . . -173.5 154.54 2.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.211 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.411 ' O ' ' OG1' ' A' ' 255' ' ' THR . 51.1 Cg_exo -51.29 -45.28 38.11 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.426 1.417 . . . . 0.0 111.925 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 254' ' ' PRO . 94.0 m -168.37 106.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.311 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 258' ' ' LEU . 72.2 m -73.44 -64.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.631 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 56.14 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 256' ' ' SER . 56.4 tp -160.69 110.66 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.043 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 260' ' ' ALA . 36.4 mmt180 -106.15 -9.68 16.82 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 259' ' ' ARG . . . 57.61 117.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.637 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.87 -39.77 95.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.615 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.37 135.9 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -88.7 -74.11 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.766 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.47 141.28 45.32 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.669 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -85.44 -12.91 50.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.435 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.64 -40.67 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.525 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -86.48 112.46 21.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.251 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.9 m -105.08 49.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 83.6 p -60.88 -35.37 76.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.46 143.99 54.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.736 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -85.08 152.85 23.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.624 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -88.97 168.79 35.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -55.89 -52.61 7.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.441 2.094 . . . . 0.0 111.451 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 89.1 mt -66.47 -40.19 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.207 0.527 . . . . 0.0 109.919 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 279' ' ' ALA . . . -59.41 -25.8 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.77 -49.37 77.98 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.575 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -65.88 -41.55 91.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.877 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -81.62 -35.35 30.16 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 275' ' ' ALA . . . -56.85 -19.74 19.14 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.178 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.42 ' O ' ' CZ ' ' A' ' 311' ' ' ARG . 32.5 p -64.36 -31.29 72.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.821 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.528 ' HB3' HG11 ' A' ' 314' ' ' VAL . 16.7 m-85 -102.83 3.7 36.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.714 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 95.0 p -85.89 -10.57 55.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 68.13 36.01 84.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -59.79 -41.28 90.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.0 -13.16 60.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -101.96 120.2 40.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 91.4 p -77.9 -11.62 59.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -92.67 13.9 18.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.231 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -52.61 149.09 6.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.431 HD23 ' HG2' ' A' ' 312' ' ' LYS . 0.3 OUTLIER -80.66 124.2 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.41 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 376' ' ' ASP . 90.2 mtm180 -74.06 148.17 42.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 370' ' ' LEU . 3.1 tt -147.66 138.78 23.55 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.314 0.578 . . . . 0.0 112.538 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 376' ' ' ASP . 21.9 m120 -124.74 150.18 46.5 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.534 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 46.1 mm -128.23 134.1 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 0.0 111.48 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 128.32 32.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -80.51 150.74 70.8 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.663 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.46 -39.19 54.69 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.476 1.451 . . . . 0.0 111.15 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 79.9 p -83.8 -19.61 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.497 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 26.4 t 42.94 69.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -72.42 -34.57 67.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 59.6 p -137.21 67.18 54.42 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.514 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.2 -17.64 40.0 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 111.412 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 37.3 t -68.65 -16.39 63.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -132.42 79.71 64.72 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.28 159.44 26.29 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.435 2.09 . . . . 0.0 111.921 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 44.2 tp -73.85 107.08 5.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -103.99 106.98 17.66 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 322' ' ' TYR . 31.5 m -137.44 159.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.599 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -95.79 129.06 43.14 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.8 142.62 51.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.532 ' HB2' HG13 ' A' ' 314' ' ' VAL . 94.8 mtt180 -74.91 159.05 32.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 110.044 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' HD23 ' A' ' 290' ' ' LEU . 99.7 mttt -79.43 -10.65 59.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.844 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -115.1 -1.67 12.96 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 311' ' ' ARG . 30.4 m -85.85 160.35 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.111 0.868 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.4 167.92 18.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.624 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 368' ' ' GLY . 82.4 t -61.58 -45.54 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.387 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 53.8 m -41.1 -30.59 0.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.695 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.28 -34.2 74.37 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 316' ' ' VAL . . . -52.63 -55.99 18.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 323' ' ' ILE . 13.8 tt -71.15 -27.14 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . -59.92 -31.91 73.62 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.188 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD2' HG11 ' A' ' 308' ' ' VAL . 5.3 t80 -72.38 -25.41 61.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.96 0.38 . . . . 0.0 111.291 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 320' ' ' ILE . 7.9 tt -49.82 -30.37 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 324' ' ' LEU . 5.0 mp -62.54 -41.47 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.711 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.95 -43.74 97.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.887 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.564 HE21 ' CD ' ' A' ' 330' ' ' GLN . 69.0 tp60 -78.56 -26.48 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 331' ' ' GLN . 88.9 t80 -60.08 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.25 -42.84 94.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.13 -43.29 98.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLN . . . . . 0.564 ' CD ' HE21 ' A' ' 326' ' ' GLN . 86.3 mt-30 -110.48 -10.54 14.54 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 327' ' ' TYR . 36.0 mt-30 41.21 53.32 3.52 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.969 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 332' ' ' LEU . 0.3 OUTLIER -102.1 150.44 23.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.129 0.49 . . . . 0.0 111.154 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 332' ' ' LEU . 28.3 t 59.03 131.68 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.956 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -37.88 158.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.154 1.903 . . . . 0.0 111.369 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.15 145.71 98.44 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.028 1.819 . . . . 0.0 111.57 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 3.4 tp -107.21 136.39 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.3 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 339' ' ' GLU . 80.9 tt0 -52.59 143.65 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.222 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -62.96 -38.95 93.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 337' ' ' GLU . 80.0 mm-40 -67.33 -12.79 61.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -79.52 -8.05 58.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.99 -39.41 94.07 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -72.64 147.74 89.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 346' ' ' TRP . 59.3 Cg_endo -70.37 -13.92 33.64 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.24 1.96 . . . . 0.0 112.242 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -65.46 -34.75 79.0 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -81.81 -34.6 30.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.034 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 380' ' ' LEU . 59.1 m95 -134.13 159.95 39.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.764 0.316 . . . . 0.0 110.257 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -117.76 150.16 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.251 0.548 . . . . 0.0 110.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 45.5 tp -108.41 120.97 43.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 358' ' ' ASP . 74.7 ttt180 -123.19 140.62 52.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.95 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 19.2 tt -75.67 152.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.6 160.15 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.315 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -77.77 174.52 10.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.2 -19.28 65.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.881 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -89.86 -2.49 58.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.55 84.71 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -82.87 169.38 16.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 0.0 110.416 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.11 153.47 39.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.422 ' O ' ' NH1' ' A' ' 349' ' ' ARG . 43.1 t0 -86.27 120.64 27.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.794 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -55.19 -19.17 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.019 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . 0.459 ' C ' ' CD2' ' A' ' 361' ' ' PHE . 73.2 m-20 -88.4 -11.05 47.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.121 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 361' ' ' PHE . 24.4 p90 29.88 62.11 0.89 Allowed Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 123.338 0.399 . . . . 0.0 111.656 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.88 157.34 55.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.537 2.158 . . . . 0.0 112.524 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -113.82 115.82 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.519 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 44.3 mt -106.39 146.93 29.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.207 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -160.45 -177.32 6.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.437 0.637 . . . . 0.0 112.098 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -57.9 -40.19 79.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.16 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.533 ' O ' HG22 ' A' ' 367' ' ' VAL . 8.8 p -79.37 -3.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 316' ' ' VAL . . . -115.67 99.56 0.9 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.78 130.37 33.79 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.651 1.567 . . . . 0.0 112.163 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.657 HD11 ' CZ ' ' A' ' 378' ' ' PHE . 44.5 tp -68.0 -39.85 83.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.726 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.4 p -63.86 -7.88 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.669 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -59.82 -46.03 90.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.52 -24.94 59.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . 76.12 16.82 80.42 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.125 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -100.63 151.37 21.7 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.754 0.777 . . . . 0.0 110.882 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 293' ' ' ASN . 39.8 p30 -109.92 26.83 10.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.414 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.506 ' O ' ' CG ' ' A' ' 378' ' ' PHE . . . -146.93 141.68 26.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.657 ' CZ ' HD11 ' A' ' 370' ' ' LEU . 98.7 m-85 -156.94 170.08 23.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.851 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -138.84 149.48 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.941 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 346' ' ' TRP . 34.4 tp -91.0 124.82 35.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.691 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.0 m -108.06 134.34 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.252 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.57 132.51 48.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.003 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -114.82 135.81 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -79.43 161.02 68.9 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 388' ' ' ILE . 69.4 Cg_exo -51.52 -35.99 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.729 1.62 . . . . 0.0 112.257 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.45 85.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.567 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.87 -30.64 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 385' ' ' PRO . 59.8 mt -62.73 -44.12 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -63.51 -41.44 98.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.642 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.81 -50.48 64.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.52 -40.72 93.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.671 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -63.07 -38.96 93.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.045 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.26 96.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.991 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.03 94.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -134.64 82.8 43.98 Favored Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.34 144.18 96.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.479 2.119 . . . . 0.0 111.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -79.22 128.61 33.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.701 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -93.92 144.57 25.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 9.6 m -72.74 146.14 46.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.828 -179.793 . . . . . . . . 0 0 . 1 stop_ save_